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Summary 
Malaria is an infectious disease of global public health importance. Despite a number of 
successful efforts to fight the disease, there are still over 200 million cases and 445,000 deaths 
each year. Plasmodium falciparum, a protozoan parasite, is the causative agent of severe 
malaria. The parasite is transmitted by female Anopheles mosquitos form human to human 
and has different life stages inside both hosts. However, the only stages that are accountable 
for clinical symptoms of the disease are asexually replicating stages in the red blood cells. 
Red blood cells are highly specialized cells lacking a nucleus, organelles and certain cellular 
mechanisms. Therefore, the parasite has to extensively remodel the erythrocyte to ensure 
survival. The remodeling is achieved by exporting a large number of proteins that have 
various functions. Those functions include nutrient update and host immune response evasion.  
A crucial part of the refurbishment process is the establishment of a protein trafficking system 
that ensures correct delivery of exported proteins to their final destination. Maurer’s clefts are 
new organelles established by the parasite in the cytosol of infected red blood cells. They are 
presumably involved in protein trafficking acting as sorting stations. A number of parasite 
exported proteins have been shown to localize permanently or transiently at Maurer’s clefts. 
Among the latter is PfEMP1, the major virulence factor of P. falciparum. PfEMP1 is exported 
from the parasite, transported to Maurer’s clefts and finally inserted in the infected 
erythrocyte membrane. The surface exposed domain of the protein is able to confer binding to 
endothelial receptors. Thus, infected red blood cells can sequester in the vasculature and avoid 
passage through the spleen where they would potentially be removed from circulation and 
eliminated.  
The aim of this project was to expand our knowledge of P. falciparum exported proteins, their 
function and interactions. In this thesis I have characterized three exported proteins, namely 
PF3D7_0702500, MESA, and STARP. In order to investigate these proteins transgenic 
parasite lines were generated and analyzed. By establishing cell lines expressing tagged 
proteins, expression and localization studies as well as co-immunoprecipitation experiments 
for the identification of protein interaction partners could be performed.  
Protein functional analysis was achieved by phenotypical characterization of knock out cell 
lines. Thereby the main readouts were growth, transport, surface presentation and anchoring 
of PfEMP1, and infected red blood cell deformability. We propose a function of 
PF3D7_0702500 in correct PfEMP1 display at the infected red blood cell surface, while the 
functions of STARP and MESA remain elusive. 
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Upon P. falciparum infection, the physical properties, e.g. cell deformability and membrane 
flexibility of an erythrocyte change dramatically. These changes are controlled by the parasite 
and are important for the adaptation to the host environment. Those biomechanical changes 
can be potentially exploited as a drug target, e.g. with drugs that reduce iRBC deformability, 
especially in circulating ring stages, enhancing the filtering function of the spleen to remove 
those iRBCs. Using microsphiltration to assess infected red blood cell deformability, we 
performed a study on the effect of the spiroindolone drug KAF246 on the rigidity of P. 
falciparum infected red blood cells. We were able to correlate these results with in vivo 
experiments where we observed P. berghei parasites accumulating in the mouse spleen 
rapidly after KAF246 treatment. 
In summary, this thesis contributes to a better understanding of the protagonists of erythrocyte 
remodeling upon P. falciparum infection and gives new insights into parasite induced host 
cell changes during the pathology relevant stages. The findings of this thesis facilitate further 
studies and may eventually lead to the identification of potential new malaria intervention 
strategies. 
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Malaria – a parasite-caused disease 
Malaria is a major global infectious disease with an estimated 216 million cases in 2016 
worldwide. The malady represents a huge social and economic burden in the tropical and 
subtropical endemic areas, mainly in Africa where >90% of an estimated 445,000 malaria 
deaths worldwide occurred in 2016 (World Health WHO, 2017). 
Human malaria is caused by 5 different Plasmodium species: P. falciparum, P. vivax, P. 
ovale, P. malaria and P. knowlesi which all differ slightly from each other in their biology. P. 
falciparum infection results in malaria tropica, the most severe form of human malaria.  
The protozoan parasite P. falciparum has a complex lifecycle including insect and human 
stages (see Figure 1). Sporozoites are transmitted to humans by female Anopheles mosquitoes 
during their blood meal. The injected sporozoites find their way to the liver, enter hepatocytes 
and start multiplication. Then, merosomes (merozoite-filled vesicles) bud of hepatocytes to 
the blood stream where thousands of daughter merozoites are released to invade erythrocytes 
(Sturm et al., 2006). During a 48h intraerythrocytic stage, the parasite grows and multiplies 
exploiting the infected red blood cells (iRBC) resources. Upon burst of the schizont, 
merozoites are released and can reinitiate the asexual reproduction cycle. A fraction of blood-
stage parasites differentiate into gametocytes (sexual form) which can be transmitted to 
mosquitoes. In the stomach of the mosquito the male and the female gametocyte fuse to a 
zygote, undergo meiosis and enter the insect’s midgut endothelium as ookinete. There, the 
ookinete matures and after several days the sporozoites leave towards the mosquito’s salivary 
gland from where they can be transmitted again to the human (White et al., 2014). 
During the parasite’s life cycle, only the intraerythrocytic stages are responsible for the 
clinical symptoms. The clinical symptoms of malaria are diverse: initial non-specific 
symptoms followed by irregular fever, nausea, and vomiting can turn into life-threatening 
conditions including anemia, coma (cerebral malaria), organ failure and death.  
For efficient and successful disease treatment it is essential to reliably and timely diagnose the 
disease. Standard diagnostics in endemic countries are microscopy of Giemsa stained blood 
smears and rapid diagnostic tests that detect parasite antigens. Molecular diagnostics by PCR 
is not adequate for the field setting as it requires sophisticated infrastructure. 
For the treatment of malaria several drugs are available and the World Health Organization 
(WHO) recommends different artemisinin-based combination therapies (ACTs). However, 
drug resistance against all currently available anti-malarials is emerging or established 
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(reviewed in Haldar et al., 2018). Despite major efforts, there is no effective, registered 
vaccine available yet.  
Current strategies to control the devastating disease are vector control (e.g. insecticides), 
exposure prophylaxis (e.g. mosquito nets), and treatment of episodes. Between 2000 and 
2015, malaria incidence and death rates dropped globally by 37% and 60%, respectively 
(Cibulskis et al., 2016). To continue the reduction of the disease the Global Technical 
Strategy for Malaria 2016–2030 has been set in place by WHO. It aims at a further 90% 
reduction in global malaria incidence and mortality by 2030 (WHO, 2015). Prerequisite for 
these ambitious goals towards the elimination of the disease are the maintenance and 
intensification of the current efforts. Crucial challenges are increasing drug and insecticide 
resistance as well as overcoming the residual transmission in low transmission areas (Bhatt et 
al., 2015).  
 
 
Figure 1: P. falciparum life cycle. The complex parasite life cycle is shown including all stages in the human 
and mosquito host. The times indicated give an impression on how long the different development stages of the 
parasite are, e.g. an asexual replication cycle in the blood takes 48 hours, reflected in the clinical symptom of 
48h interval fever episodes in malaria tropica (modified from www.mmv.org/malaria-medicines/parasite-
lifecycle). 
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Mechanisms of protein export 
The asexually replicating parasites in the blood stream are responsible for the pathogenicity of 
malaria (Miller et al., 2002). Therefore it is of high interest to better understand P. falciparum 
biology of this life stage. The red blood cell (RBC) is a terminally differentiated cell lacking a 
nucleus and essential cellular mechanisms e.g. a secretory system and a protein trafficking 
system. The intracellular parasite P. falciparum cannot exploit the host cellular machinery but 
instead has to install its own processes by extensively remodeling the erythrocyte.  In order to 
proliferate in red blood cells the parasite needs to ensure nutrient uptake, waste disposal and 
host immune evasion. These host cell adjustments are achieved by protein export (reviewed in 
de Koning-Ward et al., 2016). Thereby the parasite translocates a massive part of its proteome 
to the host cell cytosol using novel mechanisms (see Figure 2).  
 
Figure 2: Overview of the parasite protein export mechanisms. In order to reach the host cell the parasite 
proteins need to cross several membranes, including the parasite plasma membrane (PPM), the parasitophorous 
vacuole membrane (PVM), and possibly the erythrocyte plasma membrane (EPM). Depicted are the different 
intermediate players involved in the transport mechanisms, e.g. plasmepsin V for PEXEL motif cleavage, the 
PTEX translocon in the PVM, Maurer’s clefts and chaperone complexes Hsp70/Hsp40 (J-dots) in the 
erythrocyte cytosol (modified from de Koning-Ward et al., 2016). 
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P. falciparum resides in a parasitophorous vacuole (PV) inside the erythrocyte (Bannister et 
al., 1975). For the export of proteins the crossing of not only the parasite membrane but also 
the parasitophorous vacuole membrane (PVM) needs to be ensured.  
Plasmodium proteins are translated in the parasite’s cytosol and enter the secretory pathway 
to leave the cell and be exported. It is not entirely clear what signals target the protein to the 
endoplasmic reticulum (ER) in P. falciparum. Most probably, hydrophobic regions at the 
protein N-terminus function as signal sequences. It was also suggested, that N-terminal 
sequences may differ between soluble and membrane-associated secretory proteins (Meyer et 
al., 2017). Nonetheless, other post-translational modifications may be sufficient to target a 
protein for secretion (rewieved in Przyborski et al., 2016). 
The default destination of parasite proteins secreted from the ER is the PV lumen (Deponte et 
al., 2012).  
A common export motif was identified for many parasite proteins that are exported to the host 
cell cytosol, the Plasmodium export element (PEXEL) or host targeting signal (HT). This 5 
amino acid signal is composed of RxLxE/D/Q and has been found essential for export into the 
host cytosol (Hiller et al., 2004, Marti et al., 2004). To this end the PEXEL motif gets cleaved 
by the aspartic protease plasmepsin V in the ER. The cleavage happens after the leucine and 
the following amino acid gets acetylated (Boddey et al., 2009). It is the current understanding 
that the remaining amino acid residues are important for further export of the protein (Gruring 
et al., 2012, Boddey et al., 2009). However, the exact export mechanism and how it is 
influenced by the N-terminal acetylation of the protein is presently unknown.  
In addition to the classical PEXEL motif, relaxed (Boddey et al., 2013) and non-canonical 
(Schulze et al., 2015) PEXELs have been described. They differ slightly from the classical 
PEXEL motif in the amino acid sequence and can be cleaved in a specific sequence context as 
indicated by findings with different reporter proteins (Schulze et al., 2015). Based on the 
PEXEL motif approximately 450 P. falciparum proteins are predicted to be exported to the 
host cell (Boddey et al., 2013). 
Not all exported P. falciparum proteins contain a PEXEL sequence. The PEXEL-negative 
exported proteins (PNEPs) have some structural similarities among each other but no shared 
primary sequence features. It is thought that an internal hydrophobic region facilitates their 
recruitment to the secretory pathway (Spielmann and Gilberger, 2010). Grüring and 
colleagues showed that the N-terminal sequences of some PNEPs are able to drive export of a 
reporter protein, indicating a common principle in the export mechanism of those PNEPs 
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(Gruring et al., 2012). As there are no defined signature motifs for PNEPs a large proportion 
of them might be missed in predictions of the exportome. More and more PNEPs are 
identified with surprisingly diverse features, hence it could turn out that PNEPs are not the 
exception of exported proteins but make up a significant proportion of the exportome (Heiber 
et al., 2013). Several dozen PNEPs are identified to date in P. falciparum. In addition, the ~60 
variants of the major virulence factor PfEMP1 (see section below) are PNEPs. 
Even though the recognition signals of exported proteins are diverse, there is evidence for 
shared trafficking mechanisms of PEXEL and PNEP proteins. Experiments with PEXEL and 
PNEP signals in front of a reporter protein indicate that the N-termini of PNEPs are 
exchangeable with mature PEXEL proteins. Export of those reporter proteins is still working 
and indicates shared export pathways for PNEPS and PEXEL proteins relying on the N-
terminal sequence of the (mature) protein (Gruring et al., 2012). 
A multimeric protein complex called PTEX (Plasmodium translocon of exported proteins) has 
been described as PVM translocon (de Koning-Ward et al., 2009). It consists of 5 different 
components: HSP101 (ATP-powered unfoldase), EXP2 (pore), PTEX150 (structural 
component), TRX2 (redox regulation) and PTEX88 (unknown function) (reviewed in de 
Koning-Ward et al., 2016). Accumulation of PEXEL proteins and PNEPs in the PV upon 
interference with PTEX proteins PTEX150 and HSP101 indicate that all exported proteins 
cross the PVM via PTEX (Elsworth et al., 2014, Beck et al., 2014). Further, it was found that 
exported proteins need to cross the PVM in an unfolded configuration (Gehde et al., 2009, 
Gruring et al., 2012). The underlying mechanism is unclear. 
Target recognition of the PTEX translocon has not been elucidated to date. Some proteins in 
the PV are resident PV proteins and not meant for export. There are two models for the 
mechanism of target recognition: 1) bulk secretory flow and 2) PV subcompartments. Bulk 
secretory flow means that all proteins present in the PV are recognized by PTEX components 
or other chaperones in order to be translocated (Crabb et al., 2010). The PV subcompartment 
model suggests sorting of proteins in different areas/compartments of the PV. The protein 
content of specific compartments (export zones) would then be translocated. Arguing for this 
latter mechanism is the punctuate localization of PTEX in the PVM (de Koning-Ward et al., 
2009, Riglar et al., 2013) and the recent report of an Exported Protein-Interacting Complex 
(EPIC) in the PV (Batinovic et al., 2017). The authors of that study hypothesize that the 
complex is involved in protein sorting in the PV as it interacts with PTEX components and 
exported proteins. 
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Once the exported proteins crossed all membranes delivery to the final destination must be 
ensured. There is no host trafficking system that could be highjacked. Thus the parasite has to 
install its own structures to facilitate protein transport. Proteins reach their destination either 
by diffusion (soluble proteins) or in case of insoluble membrane proteins by vacuolar 
transport, in a soluble or chaperone-assisted state (Marti and Spielmann, 2013). Maurer’s 
clefts, parasite-derived membranous structures, are thought to function as protein sorting 
stations (see chapter below). The ultimate target location is probably hit via specific protein 
interaction domains. 
In summary, the parasite adapted some unconventional pathways in protein export and 
trafficking. These represent potential drug targets as they differ from host cell properties.  
 
Parasite-induced host cell modifications during the asexual intraerythrocytic 
cycle 
An estimated 10% of the entire P. falciparum proteome is exported (Spielmann and 
Gilberger, 2015). It is assumed that all these proteins fulfill a specific function in the host cell. 
Additionally, it has been estimated that a quarter of all exported proteins could be essential 
(Maier et al., 2008). Indeed several modifications of the infected erythrocyte have been 
studied which will be discussed below (see Figure 3). However the majority of putative 
exported proteins have not been investigated in detail and their function remains to be 
elucidated.  
The first compartment that exported proteins reach is the PV. The PV represents the interface 
between the parasite and the host cell and has besides its function in protein export an 
important role in nutrient uptake and waste disposal of the parasite. The proteome of the PV is 
increasingly being studied and a recent study identified a novel set of PV residing proteins, 
including three proteins important for parasite growth (Khosh-Naucke et al., 2017). PV 
residing proteins are e.g. EPIC components (Batinovic et al., 2017), proteases important for 
parasite egress (SERAs and SUB1 (Silmon de Monerri et al., 2011, Putrianti et al., 2010)) and 
PVM spanning proteins with domains in the PV e.g. PTEX components and ETRAMPs 
(reviewed in Spielmann et al., 2012). 
The tubovesicular network (TVN) is a membranous extension from the PVM to the periphery 
of the iRBC. Its function is unclear, it has been suggested to act as a transport system (e.g. of 
nutrients) across the parasite (Aikawa, 1971, Lauer et al., 1997). 
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Figure 3: Parasite-induced host cell modifications. A wide range of host cell modifications are mediated by 
exported proteins. The parasite resides in the parasitophorous vacuole (PV) from where the tubovesicular 
network (TVN) expands. In the erythrocyte cytoplasm Maurer’s clefts, Maurer’s clefts tethers, and J-dots are 
installed. Not shown are additional vesicle types. On the erythrocyte surface knobs and PfEMP1 (as 
representative of variant surface genes) are inserted mediating cytoadhesion and virulence as well as new 
permeation pathways (NPPs) ensuring nutrient uptake, waste disposal and osmotic balance. Not drawn to scale.  
 
It has been observed that P. falciparum infected erythrocytes increase their membrane 
permeability compared to uninfected erythrocytes which is thought to be due to new 
permeation pathways (NPPs) (Ginsburg et al., 1985) induced by the parasite. They have two 
proposed functions (reviewed in Desai, 2014). First, they play a role in nutrient uptake: the 
parasite retrieves most amino acids from hemoglobin by proteolytic cleavage (Sherman, 
1977). However, not all amino acids are present in a sufficient amount. Isoleucine for 
example does not occur in hemoglobin and also some additional essential compounds for the 
parasite need to be taken up from the environment, e.g. pantothenic acid (Saliba et al., 1998). 
Second, the NPPs are important for cation concentration remodeling of the iRBC: the 
intracellular Na
+ 
and K
+
 concentrations of P. falciparum infected erythrocytes are different 
from uninfected RBCs (Lee et al., 1988). The reasons for the cation remodeling are on one 
hand the prevention of osmotic lysis of infected cells and on the other hand it is assumed that 
the growing intracellular parasite adjusts the cation environment to optimize proliferation 
conditions. 
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The plasmodial surface anion channel (PSAC) is part of the NPPs (Desai et al., 2000). Yet, 
the only molecular component of the channel known to date is the CLAG3 protein which 
either forms the channel alone or interacts with other proteins to form the PSAC (Nguitragool 
et al., 2011). 
Maurer’s Clefts (MCs) are parasite-induced organelles established in the host erythrocyte 
cytosol early after parasite invasion (reviewed in Mundwiler-Pachlatko and Beck, 2013). 
They are flat, disc-shaped, membranous structures around 500nm in size thought to arise from 
the PVM (Spycher et al., 2006). MCs have been observed to move rapidly after genesis 
during the early stages of the intraerythrocytic cycle, later they stay immobilized at the 
periphery of the iRBC (Gruring et al., 2011). Their function is not well understood but they 
are assumed to play a crucial role in protein trafficking as putative sorting station because 
many exported proteins transiently localize to them. Several MC resident proteins have been 
identified e.g. MAHRP1 (Spycher et al., 2003), SBP1 (Blisnick et al., 2000), REX1 and 
REX2 (Hawthorne et al., 2004).  
Associated to MCs are Maurer’s clefts tethers which presumably play a role in anchoring and 
immobilizing MCs to the erythrocyte membrane. Electron microscopy studies characterized 
tethers as structures of 200-300nm length and around 30nm diameter with specific MAHRP2 
antibody labelling. MAHRP2 is the only resident tether protein identified so far (Pachlatko et 
al., 2010, Hanssen et al., 2010).  
J-dots are yet another structure described in the cytosol of P. falciparum iRBCs. They are 
highly mobile structures much smaller in size than MCs (estimated smaller than 30nm) and 
putatively involved in transport of exported proteins (Kulzer et al., 2010). The exported P. 
falciparum chaperone complex Hsp70x/Hsp40 has been described to localize to J-dots and 
possibly facilitate exported protein trafficking (Kulzer et al., 2012).  
Exported parasite proteins interfere extensively with the host cytoskeleton organization (see 
Figure 4) leading to changes in physical properties of the cell, e.g. altered deformability. Most 
prominent is the formation of knob structures on the surface of iRBCs. These membrane 
protrusions are built up by the knob-associated histidine-rich protein (KAHRP) and contain 
the major virulence factor PfEMP1 which is inserted into the erythrocyte membrane (Kriek et 
al., 2003, Ganguly et al., 2015). Recently, the knob structure has been studied in greater detail 
and it was found to consist of a spiral structure of a yet unknown protein which is coated by 
KAHRP and connected to the RBC cytoskeleton by multiple contacts (Watermeyer et al., 
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2016). In addition to KAHRP and PfEMP1, many members of the PHISTb protein family are 
involved in cytoskeleton refurbishment (reviewed in Warncke et al., 2016). 
 
 
Figure 4: Erythrocyte cytoskeleton remodeling. The erythrocyte cytoskeleton is undergoing extensive 
remodeling by exported proteins. Host erythrocyte proteins are shown in grey scale, in color parasite-derived 
proteins (modified from Warncke et al., 2016). 
 
Another substantial parasite-mediated host cell modification is the expression of variant 
surface antigens on the host cell surface. In P. falciparum there are three large variant surface 
antigen families: PfEMP1 (P. falciparum erythrocyte membrane protein 1) encoded by the 
var genes, STEVOR (subtelomeric variant open reading frame) encoded by the stevor genes, 
and RIFIN (repetitive interspersed repeats) encoded by the rif genes. Their roles have not 
been entirely understood but an important function of them is binding to host cell receptors 
thereby mediating on one hand cytoadherence (PfEMP1) and on the other hand rosetting 
(PfEMP1 (Rowe et al., 1997), STEVOR (Niang et al., 2014), RIFIN (Goel et al., 2015)).  
Cytoadherence means the binding of iRBCs to different endothelial host cell receptors in 
order to sequester in the tissue/vasculature thereby avoiding the passage and elimination in 
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the spleen. PfEMP1, STEVOR and RIFINs match a broad repertoire of host cell receptors, 
most extensively studied for PfEMP1. Endothelial cell surface receptors to which different 
PfEMP1 variants bind, include cluster of differentiation 36 (CD36), chondroitin sulfate A 
(CSA), intercellular adhesion molecule-1 (ICAM-1), and endothelial protein C receptor 
(EPCR) (Robinson et al., 2003, Baruch et al., 1996, Fried and Duffy, 1996, Turner et al., 
2013). 
Rosetting describes the binding of iRBCs to uninfected erythrocytes via parasite ligands and 
erythrocyte surface receptors. The exact mechanism and function of this phenomenon are still 
enigmatic but some assumptions exist (reviewed in Yam et al., 2017).  First, the uninfected 
erythrocytes shield the iRBC and the released merozoites form host invasion-inhibitory 
antibodies (Deans and Rowe, 2006). Second, the uninfected erythrocytes around the iRBC 
contribute to parasite survival and replication by presenting themselves as new host cells for 
released merozoites (Wahlgren et al., 1989).  
A variety of vesicles has been observed and described in the host cell cytoplasm. Electron 
microscopy has been instrumental in these studies. Vesicular-like structures (VLSs) are 
approximately 25nm in size (Hanssen et al., 2008, Kriek et al., 2003, Wickert et al., 2003). 
Electron dense vesicles (EDVs) are larger, about 80-100 nm (Taraschi et al., 2003, Hanssen et 
al., 2010). Several exported proteins, e.g. PTP2, PfEMP1, PfEMP3 associate to EDVs and 
they may have a role in PfEMP1 transport from the MCs to the erythrocyte surface (Hanssen 
et al., 2010, McMillan et al., 2013, Trelka et al., 2000). Additionally, it has been suggested 
that extracellular vesicles from iRBCs are immunomodulatory (Mantel et al., 2013), have a 
function in parasite-to-parasite gene transfer (Regev-Rudzki et al., 2013) and are involved in 
PfEMP1 display (Sampaio et al., 2018). The existence and proposed functions of those 
microvesicles are highly disputed.   
Aberrant RBC properties like they occur in hemoglobinopathies influence parasite protein 
export and the structures established by the parasite. For example, in infected sickle cell 
disease RBC anomalous MCs, actin and knobs structures lead to reduced cytoadherence 
(Cyrklaff et al., 2011, Kilian et al., 2015). Not surprisingly, the sickle cell trait is highly 
prevalent in malaria endemic areas (Piel et al., 2010) as heterozygous carriers of the sickle 
cell hemoglobin (HbS) have a 10-fold lower risk to die from malaria (Aidoo et al., 2002).  
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PfEMP1 characteristics and transport 
PfEMP1 is the major virulence factor of P. falciparum. It mediates iRBC cytoadhesion and 
sequestration thereby contributing greatly to the clinical disease symptoms by disrupting the 
blood flow in the vasculature.  
PfEMP1 is encoded by the var gene family which has approximately 60 members (Gardner et 
al., 2002). All PfEMP1 variants have a similar structure: an N-terminal segment (NTS), 
varying combinations of Duffy binding ligand (DBL), cysteine-rich inter-domain regions 
(CIDRs), a transmembrane domain, and the intracellular C-terminal cytoplasmic acid terminal 
segment (ATS) (Su et al., 1995). The extracellular part of the protein (NTS, DBL, and 
CIDRs) is highly variable facilitating the interaction with different host cell receptors (Deitsch 
and Hviid, 2004) and antigenic variation (Biggs et al., 1991). Further, expression of PfEMP1 
is mutually exclusive, meaning that one single infected erythrocyte displays exactly one 
PfEMP1 variant on the surface (Dzikowski et al., 2006). The exact molecular mechanism 
behind the ability of the parasite to change the expression of the PfEMP1 variant remains 
elusive. However, the variability in antigenicity and cytoadhesive properties mediated by var 
gene expression switching are assumed to be key properties for host immune response 
evasion (reviewed in Hviid and Jensen, 2015).  
PfEMP1 is displayed at knob structures on the surface of iRBCs (Kriek et al., 2003, Ganguly 
et al., 2015). An interaction between the PfEMP1 ATS domain and KAHRP has been 
identified in vitro (Waller et al., 1999) but could not be confirmed (Mayer et al., 2012). 
Further, the PHISTb family protein PFE1605w (LyMP) plays a role in anchoring a subset of 
PfEMP1s to the host cytoskeleton (Oberli et al., 2014, Oberli et al., 2016). 
Despite the crucial role of PfEMP1 surface display in malaria pathology and immunology, our 
understanding of its transport is only fairly established. A model of PfEMP1 trafficking was 
proposed by Batinovic and colleagues (see Figure 5, (Batinovic et al., 2017)).  
There is evidence implying that the integral membrane protein PfEMP1 is trafficked in a 
chaperone-assisted manner from the PVM to Maurer’s clefts. Components of the human 
TRiC (TCP1 ring complex, a type II chaperonin complex) support the transport of PfEMP1 
(Banumathy et al., 2002, Batinovic et al., 2017). The respective P. falciparum TRiC is 
probably not involved in PfEMP1 delivery (Spillman et al., 2017). 
The intermediate stations of PfEMP1 on the way to the erythrocyte membrane are MCs 
(Kriek et al., 2003). Several MC resident proteins are essential for PfEMP1 presentation on 
the host cell surface, e.g. MAHRP1 (Spycher et al., 2008), SBP1 (Cooke et al., 2006), PTP2 
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(Maier et al., 2008) and REX1 (Dixon et al., 2011). Probably, Maurer’s clefts proteins 
stabilize PfEMP1 at the MCs membrane and help target it for further transport. 
 
 
Figure 5: PfEMP1 trafficking model. The current understanding of the transport mechanism of the major 
virulence factor PfEMP1 from the parasite to the erythrocyte membrane is shown including secretion from the 
endoplasmic reticulum (ER) to the parasitophorous vacuole (PV) where it is recognized by the Exported Protein-
Interacting Complex (EPIC), transported through the Plasmodium translocon of exported proteins (PTEX) and 
then with help of the human TCP1 ring complex (huTRiC) shuttled to the Maurer’s clefts. There it is inserted in 
the membrane, putatively packed into electron dense vesicles (EDVs) and transported along tethers to be inserted 
into knobs (Batinovic et al., 2017). 
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Electron microscopy studies found PfEMP1 associated to EDVs (Trelka et al., 2000, Cyrklaff 
et al., 2011). Therefore it is hypothesized that PfEMP1 is transported form Maurer’s clefts to 
the RBC surface in a vesicle-assisted manner (McMillan et al., 2013).  
Recently, physical organization of PfEMP1 in the different compartments was investigated by 
protease protection assays. Those assays revealed that PfEMP1 is non-membrane embedded 
in the PV (Batinovic et al., 2017) and the N-terminal domain is embedded in MCs (Batinovic 
et al., 2017, Kriek et al., 2003). 
Additional proteins have been reported to have a function in PfEMP1 trafficking, e.g. PTP1-6 
(Maier et al., 2008), VAP1 (Nacer et al., 2015), and Hsp70x (Charnaud et al., 2017). 
However, their exact location and detailed mode of action needs to be elucidated.  
 
Immune evasion strategies and the role of the spleen 
To thrive in a host(ile) environment, P. falciparum must establish immune evasion strategies. 
In the human host there are 1) the asymptomatic pre-erythrocytic stages (sporozoite, and the 
infected liver cell) and 2) the clinically relevant intraerythrocytic stages (asexual and sexual 
stages) that have to escape the host immune system.  
Upon entry of the human body, the sporozoite enters the blood stream, traverses Kupffer cells 
(liver-resident macrophages) and endothelial cells and subsequently infects hepatocytes. The 
parasite acquired strategies to suppress the phagocytic characteristics of Kupffer cells thereby 
avoiding its elimination (Usynin et al., 2007). In the hepatocyte the parasites develop further 
and modifies selective autophagy processes to its advantage (Prado et al., 2015).  
In intraerythrocytic stages the expression of variant surface antigens and the alteration of 
biomechanical properties of the iRBC are instrumental for immune evasion.  
iRBC sequestration mediated by variant surface antigens (see previous section) results in 
avoidance of iRBC spleen passage which potentially could lead to their removal form the 
circulation. It has been reported that iRBCs from splenectomized malaria patients lost variant 
surface antigen expression supporting their importance in spleen passage avoidance 
(Bachmann et al., 2009). IRBCs have increased stiffness compared to normal erythrocytes 
(Cranston et al., 1984). This makes them a target of the spleen that recognizes and removes 
altered erythrocytes from the circulation, e.g. senescent RBCs or iRBCs. Splenomegaly 
(enlarged spleen) is a typical symptom of malaria patients. Besides filtering aberrant cells 
(mechanical function), the spleen has also a major role in the immune response to malaria 
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infection (reviewed in Del Portillo et al., 2012). For example, the spleen red pulp hosts 
macrophages that are involved in removal of iRBCs by phagocytosis (Yadava et al., 1996). 
Else, splenic resident classical dendritic cells can take up parasite material and subsequently 
present Plasmodium peptides to T-cells (Sponaas et al., 2006). Splenectomized patients have 
impaired clearance of the parasite upon drug treatment implicating the crucial role of the 
organ in parasite removal (Demar et al., 2004). Pitting is an additional function of the spleen. 
It refers to the removal of the parasite form the erythrocyte, preserving the host erythrocyte 
(Schnitzer et al., 1972, Chotivanich et al., 2000, Buffet et al., 2011). 
The importance of iRBC biomechanical changes in immune evasion is reflected in the 
deformability properties of gametocytes throughout maturation. Sequestered gametocyte 
stages II-IV iRBCs have very limited deformability. This probably contributes to their 
retention in the bone marrow (Tiburcio et al., 2012, Joice et al., 2014). Interestingly, 
gametocyte stage V iRBCs are highly deformable, presumably allowing the parasite to leave 
the bone marrow and circulate through the spleen. This is crucial for transmission to the 
mosquito in order to continue the life cycle (Tiburcio et al., 2012, Aingaran et al., 2012). 
 
Approaches in functional analysis of red blood cell stage P. falciparum proteins 
The generation of transgenic parasites is an important tool for functional gene and protein 
studies. Thereby, genetic gene knock out and knock in lines enable a better understanding of 
the parasites biology. In recent years, great advances have been made in genome editing 
techniques in P. falciparum (reviewed in de Koning-Ward et al., 2015). Transfection-based 
methods are used for P. falciparum asexual red blood cell stages to introduce DNA 
sequences. Most relevant for this thesis are conventional recombination, the CRISPR-Cas9 
system (Ghorbal et al., 2014), and the Selection Linked Integration (SLI) approach (Birnbaum 
et al., 2017).  
There is a broad variety of assays used to investigate cellular processes influenced by the 
protein/gene of interest. After a basic characterization of the newly generated transgenic cell 
line (expression and localization studies), more sophisticated experiments are performed to 
identify putative interaction partners of the protein of interest. Further, functional analysis of 
knock out cell lines is undertaken.  
There is a particular interest in characterizing proteins involved in the processes of parasite 
virulence and immune evasion in order to better understand parasite biology and identify 
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intervention targets. Hence, transport and presentation of PfEMP1 on the iRBC as well as 
biomechanical changes of iRBCs are significant readouts of functional analyses.  
The trypsin cleavage assay is commonly used to test for PfEMP1 presentation on the host cell 
surface. Thereby the iRBCs are trypsin treated in order to cleave the surface exposed part of 
PfEMP1. Subsequently, PfEMP1 is extracted from the membrane and Western blot analysis is 
performed using an antibody against the intracellular domain of PfEMP1 which allows 
conclusions about the exposure of PfEMP1 on the RBC surface. If PfEMP1 is present on the 
RBC surface and thus cleaved by trypsin, a shorter fragment is detected. If PfEMP1 is not 
presented on the erythrocyte surface but intracellular and thus is not cleaved by trypsin, a 
longer fragments (representing full-length, intracellular PfEMP1) is detected. 
Another set of assays to assess the quality of PfEMP1 anchoring in the erythrocyte membrane 
are semi-static binding assays. A culture dish is coated with recombinant human endothelial 
receptors (e.g. CD36, ICAM-1, CSA) and iRBCs are incubated on it under shaking (semi-
static) conditions. The shaking should mimic the blood flow. After incubation bound cells are 
quantified and conclusions about binding, presentation and anchoring of the expressed 
PfEMP1 variant can be drawn.  
There is a wide range of techniques available to measure biomechanical properties, e.g. 
deformability of iRBCs, each with advantages and disadvantages. There is the possibility to 
measure deformability specifically of the iRBC membrane e.g. by micropipette aspiration 
(Glenister et al., 2002) or atomic force microscopy (Dulinska et al., 2006). In order to assess 
deformability of the entire iRBC, e.g. microfluidics (Matthews et al., 2017), microsphiltration 
(Lavazec et al., 2013), or ectacytometry (Dondorp et al., 1999) are used. 
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Aims 
The general aim of this thesis was to further elucidate the role and function of a number of P. 
falciparum exported proteins in the host red blood cell. Protein transport and trafficking 
mechanisms established by the malaria parasite in the erythrocyte are different from classical 
mechanisms of the host. Thus a better understanding of the parasite biology could lead to the 
identification of potential new strategies to target the parasite.  
Maurer’s clefts (MC) are parasite induced organelles involved in trafficking of exported 
proteins. Correct and timely delivery of exported proteins to their target site is crucial for the 
parasite to establish itself in the host cell. A number of exported proteins have been found to 
localize at the MC either transiently (e.g. PfEMP1) or permanently (e.g. MAHRP1, SBP1, 
REX1). Putative anchoring structures of MCs are MC tethers, with MAHRP2 as the only 
resident protein of these structures identified today. In order to better understand the role and 
function of MCs and MC tethers we performed co-immunoprecipitation experiments with 
MAHRP1 and MAHRP2 followed by mass spectrometry. By functional characterization of 
putative interaction partners of these proteins we wanted to expand our understanding of the 
interaction network of exported proteins and their integration into host cellular structures such 
as the erythrocyte cytoskeleton. In this project the focus lies on PF3D7_0702500 (also known 
as PF07_0008), MESA (mature-parasite-infected erythrocyte surface antigen, 
PF3D7_0500800), and STARP (sporozoite threonine and asparagine-rich protein, 
PF3D7_0702300) which all were identified in MAHRP2 and/or MAHRP1 co-
immunoprecipitation experiments. Of particular interest is their involvement in the PfEMP1 
delivery process to the iRBC surface and parasite-induced rigidity changes of the iRBC.   
 
Specific aims:  
1) Characterization of  PF3D7_0702500, MESA, and STARP (chapter 2, 3, 4) 
Protein characterization will be performed on the basis of transgenic cell lines 
(introduction of endogenous gene tags and gene knock out). These are going to be 
generated by applying the recently established CRISPR/Cas9 technology and a novel 
approach of a combined CRISPR/Cas9-selection-linked integration strategy. 
Expression and localization of the proteins of interest will be analyzed as well as 
interaction partners will be identified by co-immunoprecipitation experiments. 
Phenotypical analysis of knock out cell lines will be undertaken for functional 
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characterization of the proteins. To this end, special attention of their role in altering 
the biomechanical properties of the iRBC and in PfEMP1 transport will be paid. 
Adopted methods will include growth assay, microsphiltration (see aim 2), trypsin 
cleavage assay and binding assay. 
 
2) Assessment of iRBC rigidity changes as protein functional readout after genetic 
manipulation of the parasite (chapter 2 and 3) and upon spiroindolone KAF246 
treatment (chapter 5) 
Biomechanical alterations of the host erythrocyte are instrumental for parasite 
virulence and immune evasion. One method to assess these is microsphiltration. The 
microsphiltration technique will be learnt during a research visit in Paris and 
subsequently established at the Swiss TPH during my thesis. This versatile tool will be 
used to assess rigidity changes a) during the parasite life cycle in knock out cell lines 
(functional protein studies) and b) upon anti-malarial drug exposure. To this, a study 
on the effect of spiroindolones on iRBCs deformability will be performed in 
collaboration with the Parasite Chemotherapy Unit, Swiss TPH.  
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Introduction 
Plasmodium falciparum is the causative agent of the most severe form of human malaria and 
accountable for an estimated 445,000 deaths in 2016 (World Health WHO, 2017). The 
asexual development of the protozoan parasite within the red blood cell (RBC) is associated 
with clinical symptoms of the disease, while the sexual forms (gametocytes) are crucial for 
transmission to the mosquito and thus the maintenance of the life cycle. Erythrocytes are 
highly specialized cells lacking organelles and specific cellular mechanisms e.g. a protein 
trafficking system. P. falciparum extensively modifies the red blood cell to thrive. Essential 
changes mediate host immune evasion and enable nutrient uptake. The refurbishment process 
is driven by parasite proteins that are exported to the host cell. To ensure proper protein 
delivery to target sites, the parasite needs to establish a trafficking system as no existing host 
pathways can be exploited. Maurer’s clefts are parasite-derived organelles installed in the 
cytoplasm of the infected RBC (reviewed in Mundwiler-Pachlatko and Beck, 2013). Their 
function is not entirely clear but they are thought to be important sorting stations of already 
exported proteins. Depletion of several resident Maurer’s clefts proteins prevents P. 
falciparum erythrocyte membrane protein 1 (PfEMP1) presentation on the erythrocyte surface 
e.g. MAHRP1 (Spycher et al., 2008), SBP1 (Cooke et al., 2006), and REX1 (Dixon et al., 
2011). PfEMP1 is the major virulence factor of P. falciparum mediating cytoadherence of 
infected erythrocytes to the microvasculature enabling the parasite to avoid spleen passage 
resulting in clearance from the circulation (Hviid and Jensen, 2015). 
P. falciparum exports ~10% of its entire proteome to the erythrocyte cytoplasm (Spielmann 
and Gilberger, 2015). This enormous number hints at the critical role of host cell 
refurbishment for parasite development. Thus, a better understanding of the function of 
exported proteins and in particular of PfEMP1 trafficking mechanisms could lead to the 
identification of new targets for therapy, or even lead towards a vaccination with attenuated 
parasites. 
Exported proteins can be divided in two groups: 1) those that carry a common Plasmodium 
export element (PEXEL) motif (RxLxE/Q/D) (Hiller et al., 2004, Marti et al., 2004), and 2) 
those devoid of a PEXEL motif which are summarized as PEXEL-negative exported proteins 
(PNEPs). PNEPs have structural similarities but no shared primary sequence features and they 
are therefore difficult to predict. A study from Heiber and colleagues suggested that there are 
several dozens of PNEPs in P. falciparum (Heiber et al., 2013).  
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In order to elucidate the interaction network of exported proteins, their functions, and their 
integration into host cellular structures we previously performed co-immunoprecipitation 
experiments with SEMP1 (a Maurer’s clefts protein) (Dietz et al., 2014) and MAHRP2 (a 
Maurer’s cleft’s tether protein) (unpublished). One of the common putative interaction 
partners identified by mass spectrometry was the PNEP PF3D7_0702500.  
Here, we characterized the PNEP PF3D7_0702500 which is expressed throughout the 
intraerythrocytic stages and localizes to electron-dense structures. Our results suggest that 
PF3D7_0702500 contributes to efficient transport of PfEMP1 between Maurer’s clefts and 
the erythrocyte membrane, or its reduced anchoring at the cytoskeleton. 
 
Methods 
Cell culture and transfections 
P. falciparum 3D7 was cultured and transfected as described (Moll et al., 2013). Transfected 
parasites were positively selected with 10nM WR99210 (Jacobs Pharmaceuticals, Cologne, 
Germany), 5mg/ ml blasticidin (Sigma-Aldrich, Inc.), negative selection was done with 1µM 
5-Fluorocytosine (Valeant Pharmaceuticals, Laval, CA). 
 
Plasmid constructs  
3xHA-tagging at the 3’ end generating PF3D7_0702500-3xHA was achieved using a 
combined CRISPR-Cas9/SLI approach (Ghorbal et al., 2014, Birnbaum et al., 2017). 
Homology regions between 400-550bp were designed, and a gRNA close to the genes 5’ end 
was chosen using the CHOPCHOP software (Labun et al., 2016, Montague et al., 2014). The 
gRNA recognition sequence was mutated on the homology plasmid sequences to avoid 
cleavage of successfully tagged endogenous protein. Mutations were introduced with PCR 
primers. The homology regions and gRNA were PCR amplified using primers listed in 
Supplementary Table 1 and cloned into pCRISPR_HA2ABSD using the In-Fusion® HD 
Cloning Kit (Clontech® Laboratories, Inc.). pCRISPR_HA2ABSD contains the Cas9, the 
gRNA, and the integration cassette flanked by homology regions. The integration cassette 
consists of the 3xHA-tag and a blasticidine resistance gene separated by a 2A skip peptide 
(Szymczak et al., 2004) and a hrp2 terminator. The blasticidine gene lacks a promotor and can 
only be expressed after successful integration into the target locus. The skip peptide triggers a 
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ribosomal skip mechanism and thus impairs normal peptide bond formation preventing the 
attachment of the selection marker to the target protein (Donnelly et al., 2001). 
The PF3D7_0702500 KO was generated with a two plasmid CRISPR-Cas9 approach using 
pUF_Cas9 and pL7 (obtained from Ghorbal et al., 2014). 350-500bp homology regions were 
designed and a gRNA was chosen as described. The homology regions and gRNA were PCR 
amplified using primers listed in Supplementary Table 1 and cloned into pL7 using the In-
Fusion® HD Cloning Kit (Clontech® Laboratories, Inc.). 
 
Western blot analysis 
Parasite saponin lysates were run on 4-12% Bis/Tris precast gels (NuPAGE®, Life 
Technologies) according to the manufacturers’ protocol. Protein transfer was performed with 
the iBlot 2.0 (Life Technologies). Subsequently the membrane was blocked with 10% 
skimmed milk/TNT (0.1% Tween in 100mM Tris, 150mM NaCl-buffer) and probed with a 
first antibody in 3% skimmed milk/TNT at room temperature for 2h or overnight. After 6 
washes for 5min with TNT the secondary antibody conjugated to HRP was incubated in the 
respective dilution in 3% skimmed milk/TNT for 2h at room temperature. After another 6 
washes for 5min with TNT the signal was detected by Super Signal West Pico 
Chemiluminescent Substrate (Thermo Scientific) or LumiGlo Reserve Chemiluminescent 
Substrate (Seracare) according to the manufacturers’ protocol. The antibodies used were: 
rabbit α-MAHRP1 (1:5’000), rat α-HA (Roche, 1:1’000), mouse α-GAPDH (1:20’000), rabbit 
α-PFE1605w (1:1’000), mouse α-ATS (1:500), goat α-mouse-HRP (Pierce, 1:5’000), α-rat-
HRP (Pierce, 1:10’000), goat α-rabbit-HRP (Pierce, 1:10’000). 
 
Fluorescence microscopy 
Thin blood smears of infected parasite cultures were fixed in ice-cold 60% methanol/40% 
acetone for 2min. After air-drying of the smear, a small circle was drawn with a hydrophobic 
pen and the respective area was blocked with 3% BSA/PBS for 1h at room temperature in a 
humidified chamber. Then, the cells were incubated with mouse α-MAHRP1 (1:100), rabbit 
α-MAHRP2 (1:100), mouse α-ATS (1:50), rat α-HA (Roche, 1:100), mouse α-GFP (Roche, 
1:100), mouse α-PFI1780w (1:1000) in 3% BSA/PBS for minimum 2h at room temperature in 
a humidified chamber. After 3 washes with 3% BSA/PBS for 7min the secondary antibody 
(goat α-mouse Alexa488, goat α-rabbit Alexa488, goat α-rabbit Alexa568, goat α-rat 
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Alexa568 (all Invitrogen,  1:200)) was applied in 3% BSA/PBS for a minimum of 1h at room 
temperature in a humidified chamber. After another 3 wash steps with 3% BSA/PBS for 7min 
each a coverslip was mounted with 2µl VECTASHIELD® with DAPI (Vector Laboratories 
Inc.). For imaging a 63x oil-immersion lens (1.4 numerical aperture) on a Leica 5000 B 
microscope was used. The images were obtained by using the software Leica 
ApplicationSuite 4.4. and analyzed using FiJi (Schindelin et al., 2012). 
 
Confocal microscopy 
2.5ml of infected parasite cultures were pelleted and all subsequent steps were performed in 
Eppendorf tubes. Cells were fixed for 30min in 1ml 4% formaldehyde/0.01% glutaraldehyde 
in PBS on a rotator at room temperature. After washing 6 times with PBS, membrane 
permeabilization was achieved by incubating the pellet for 10 min in 500 µl 0.1% Triton X-
100 in PBS at room temperature on a rotator followed by 3 washes in PBS. Unspecific 
binding sites from glutaraldehyde were blocked by incubating the sample for 10min in 500µl 
0.1mg/ml NaBH4 in PBS at room temperature on a rotator. After 3 times washing with PBS, 
blocking was performed in 3% BSA/PBS for 1h at room temperature on a rotator. The first 
antibody (rat α-HA (Roche, 1:100), mouse α-GFP (Roche, 1:100), mouse α-PFI1780w 
(1:1000), mouse α-ATS (1:50)) was diluted in 100µl 3% BSA/PBS and incubated 1-2h at 
room temperature on a rotator. Then 5 wash steps with PBS were performed. The secondary 
antibody (goat α-mouse Alexa488, goat α-rat Alexa568, both Invitrogen, 1:200) was diluted 
in 3% BSA/PBS and incubated 1-2h at room temperature on a rotator in the dark. After 5 PBS 
washes, the cell pellet was resuspended in 50-100µl PBS and mixed 1:1 with 
VECTASHIELD® with DAPI (Vector Laboratories Inc.). Approximately 5µl of cells were 
put on a microscopy slide, covered by a coverslip which was fixed and sealed with nail polish. 
The slides were imaged with a Zeiss LSM 700 confocal microscope (Carl Zeiss GmbH, Jena, 
Germany), with a 63x oil-immersion lens (1.4 numerical aperture). Colocalization analysis 
was performed with deconvoluted pictures (Huygens Remote Manager, Ponti et al., 2007) by 
using Fiji (JACoP plugin, Schindelin et al., 2012).  
 
Solubility assay 
10ml asynchronous parasite infected cell cultures were lysed in 0.03% saponin for 10min on 
ice. Cell pellets were washed 3x with PBS and resuspended in 200µl 5mM Tris-Cl (pH 8) 
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with cOmplete protease inhibitor cocktail (Roche). The sample was frozen at -80°C. After 
centrifugation for 10min at 16’000g at 4°C the supernatant was saved as hypotonic fraction 
(soluble protein fraction). The pellet was washed 5 times in 5mM Tris-Cl (pH 8) and then 
resuspended in 200µl 0.1 M Na2CO3 (pH 11) with protease inhibitor and incubated 30min on 
ice. After centrifugation for 10min at 16’000g at 4°C the supernatant was saved as carbonate 
fraction (peripheral membrane protein fraction). The pellet was washed 5 times in 0.1M 
Na2CO3 (pH 11) and then resuspended in 200µl 1% Triton-X-100 in PBS with protease 
inhibitor and incubated 30min on ice. After centrifugation for 10min at 16’000 g at 4°C the 
supernatant was saved as integral fraction (integral membrane protein fraction). The 
remaining pellet was resuspended in 200µl 4% SDS/0.5% Triton-X-114/.5x PBS and defined 
as Triton insoluble fraction. Equal amounts of all fractions were assessed by Western blot. 
 
Co-Immunoprecipitation  
150ml synchronized parasite culture was harvested by Percoll to enrich late stages. Proteins 
were cross-linked with 1% formaldehyde in culture media for 30min on a rotator at 37°C. 
Cross-linking was stopped by adding glycine to a final concentration of 0.3M. The red blood 
cells were subsequently lysed with 0.03% saponin for 10min at 4°C. Afterwards the pellet 
was resuspended in sonication buffer (50mM Tris-HCl pH 8, 10mM EDTA, 1% SDS, 
cOmplete protease inhibitor cocktail) and sonicated for 15min (30 sec on/30 sec off) in a 
Bioruptor UCD-300. The fraction containing the protein of interest (bait) was determined by 
Western blot analysis. For the Co-immunoprecipitation the sample and the control were 
divided into 4 replicates each. 350µl sonication supernatant was mixed with 350µl 2x binding 
buffer (50mM Tris-HCl pH 7.4, 300mM NaCl, 2% Nonidet 40, cOmplete protease inhibitor 
cocktail) and for the negative control additionally 75µg HA-peptide (Sigma) was added. 
Samples were mixed with 80µl PierceTM α-HA Magnetic Beads (Thermo Scientific) and 
incubated at 4°C overnight at 25rpm. Beads were pelleted with a magnet and washed 4 times 
with washing buffer (50mM Tris-HCl pH 7.4, 150mM NaCl, 1mM EDTA, 1% Nonidet 40, 
cOmplete protease inhibitor cocktail). Finally, the beads were incubated with 30µl elution 
buffer (0.5mg/ml HA-peptide in 1x binding buffer) at 25rpm for 2h at 4°C. The supernatant 
was kept as elution, and mixed with sample buffer. The eluted fraction was analyzed by Silver 
Gel (SilverQuest, Invitrogen) and Western blot before LC-MS/MS analysis.  
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MS sample preparation 
Samples were loaded onto a 4%-12% gradient Bis-Tris gel (Thermo) and run in 1x MOPS 
buffer at 180V for 10min. Each lane was sliced, minced and transferred to an Eppendorf 
reaction tube. In gel digest was performed as previously described (Bluhm et al., 2016) and 
samples stored on StageTips (Rappsilber et al., 2007) until measurement. Alternatively, for 
biotin proximity ligation experiments, the beads were directly incubated in 2mM DTT/50mM 
ammoniumbicarbonate buffer (Sigma-Aldrich) and subsequently alkylated with 5mM 
iodoacetamide (Sigma-Aldrich). Digestions were performed with 200ng of trypsin (Sigma-
Aldrich) in 2M urea/50mM ammoniumbicarbonate buffer at room temperature overnight. 
Tryptic peptides were stored on StageTips (Rappsilber et al., 2007) until measurement. 
 
MS measurement 
The digested peptides of the samples were separated on a 25-cm reverse-phase capillary (75 
µM inner diameter, New Objective) packed with Reprosil C18 material (Dr. Maisch GmbH). 
Elution of the peptides was achieved with a 2h gradient from 2%-40% Buffer acetonitrile 
followed by a 95% acetonitrile wash-out at 200nl/min on an Easy LC1000 HPLC system 
(Thermo). Mass spectrometry measurements were performed with a Q Exactive Plus mass 
spectrometer (Thermo) operated with a Top10 data-dependent MS/MS acquisition method per 
full scan. Spray voltage was set to 2.2-2.4 kV. 
 
MS data analysis 
MS raw data was analyzed using MaxQuant v1.5.2.8 (Cox and Mann, 2008) with standard 
settings and activated match between runs and LFQ quantitation features. The search was 
performed against a Human Uniprot database (81,194 entries) and the Plasmodium 
falciparum PlasmoDB 9.3 database (5,538 entries). The proteinGroups file was filtered for 
known contaminants and reverse hits prior to statistical analysis (Welch t-test). Data was 
plotted using the R environment (http://www.R-project.org). 
 
Growth assay 
Asynchronous parasite infected cell cultures were set up at 0.2% parasitemia. Parasitemia was 
determined by flow cytometry and followed over 5 days. Parasites were stained with SYBR® 
Green I nucleic acid gel stain (Sigma-Aldrich) 1:5000 for 20min at 37°C in the dark, washed 
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3x with culture medium and 100’000 cells were assessed with a BD FACSCalibur. The 
experiment was performed in biological triplicates, standard deviations were calculated and 
exponential curves fitted to the data points. 
 
Deformability assay 
Microsphiltration experiments were performed as described by Lavazec et al. (2013). Tightly 
synchronized parasite cultures (600µl, 0.5-10% parasitemia, 1.5% hematocrit) were passed 
under flow (60ml/h) through a microsphere matrix consisting of solder powder beads from 5-
15µm and 15-25µm diameter (Industrie des Poudres Sphériques, Annemasse, France). After 
rinsing the column with 5ml of culture medium, parasitemia of input and flow through 
samples were assessed by flow cytometry. Parasites were stained with SYBR® Green I 
nucleic acid gel stain (Sigma-Aldrich) 1:5000 for 20min at 37°C in the dark, washed 3x with 
culture medium and 100’000 cells were assessed with a BD FACSCalibur. All experiments 
were performed in technical triplicates. Retention rates (in %) were calculated as 
1−(parasitemia flow through sample/parasitemia input sample). 
 
Binding assay 
Semi-static binding assays were performed as published previously (Oberli et al., 2016). 
Human CD36 recombinant protein (Sino Biological, China) was spotted on wells of eight-
chamber cell culture glass slides (Falcon, Big Flats, NY, USA) with 50µg/ml concentrations 
and incubated overnight at 4°C to allow proteins to absorb to the surface. The wells were 
blocked with 1% BSA/PBS for 1h at 37°C. Parasite cultures were washed twice with RPMI-
HEPES and spotted onto immobilized CD36 and cultured for 2h under continuous and 
simultaneous shaking (140rpm, proBlot 25 Rocker; Labnet International Inc., NY, USA) 
(105rpm, Lab-Therm LT-W, Kühner, Switzerland) at 37°C. Non-bound erythrocytes were 
removed by six gentle washes with RPMI-HEPES with simultaneous shaking for 2min. 
Bound iRBCs were fixed with 2% glutaraldehyde in RPMI-HEPES overnight, stained with 
10% Giemsa for 1h and microscopically counted. Results are shown as relative mean number 
of parasites bound per square millimeter and normalized to 1% parasitemia and 3D7. The 
experiment was performed in biological triplicates. 
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Trypsin cleavage assay 
Percoll-purified late stage parasites were digested for 15min at 37°C either in 100μg/ml L-
(tosylamido-2-phenyl) ethyl chloromethyl ketone-treated trypsin (Sigma)/PBS or in trypsin 
and 1mg/ml soybean trypsin inhibitor (Sigma)/PBS. The reaction was stopped by adding 
soybean trypsin inhibitor to a 1mg/ml final concentration. PfEMP1 extraction and subsequent 
Western blot analysis was performed as previously described (Van Schravendijk et al., 1993, 
Waterkeyn et al., 2000). 
 
PfEMP1 expression typing by quantitative real-time PCR 
PfEMP1 transcript diversity in the respective parasite cultures was performed as previously 
described (Dahlback et al., 2007). Total RNA was extracted from ring stage infected red 
blood cells dissolved in RiboZol (Amresco). Subsequently, qRT-PCR was performed on 
complementary DNA synthesized from total RNA with gene specific primers for each 3D7 
var gene to determine relative copy numbers compared to internal control transcripts. 
 
Immunoelectron microscopy 
For immunoelectron microscopy, mature parasites were knob-selected, purified by Percoll 
density gradient, fixed in 2% paraformaldehyde/ 0.2% glutaraldehyde in phosphate buffer 
pH7.4, half of them were treated with Tetanolysin (Sigma) and prepared according to 
Tokuyasu (1973). Ultrathin sections (70nm) prepared on a FC7/UC7-ultramicrotome (Leica) 
at -120°C were immuno-gold labeled with rabbit α-HA (dilution 1:60, Invitrogen) or rabbit α-
MAHRP2 (dilution 1:20) antibodies and finally decorated with 5 or 10nm protein A-gold 
(1:70) (UMC, Utrecht, The Netherlands). Sections were stained with 4% uranyl 
acetate/methylcellulose (1:9) and examined with a Tecnai G2 Spirit or CM100 Philips 
transmission electron microscope (TEM) at 80kV. 
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Results 
Expression and localization of PF3D7_0702500 
PF3D7_0702500 is located on chromosome 7 and has a two exon structure encoding a 253 
amino acid long protein with a predicted transmembrane domain.  
We used a combined CRISPR/Cas9-SLI approach (Ghorbal et al., 2014, Birnbaum et al., 
2017) to introduce a 3xHA-tag at the PF3D7_0702500 C-terminal end (Figure 1A). Correct 
integration of the tag-cassette was verified by PCR (data not shown). The expression of the 
fusion-protein was analyzed by Western blot (Figure 1B) and a signal running at around 
40kDa was observed although the calculated molecular weight of PF3D7_0702500-3xHA is 
31kDa. As expected there was no HA-signal detected in the 3D7 control lysate. The faint 
band above 50kDa is PF3D7_0702500-3xHA-2A-BSD, where the skip peptide was not 
cleaved efficiently (α-bsd Western blot not shown).  
Information about expression and localization of PF3D7_0702500-3xHA throughout the 
asexual intraerythrocytic life cycle was obtained by time course immunofluorescence assays 
and Western blot analysis (Figures 1C and D). PF3D7_0702500-3xHA is expressed and 
exported throughout the entire asexual life cycle with a peak in the late trophozoite/schizont 
fraction, and the protein localizes in a punctuate manner in the infected red blood cell (iRBC) 
cytosol. Well-known structures in the erythrocyte cytosol are Maurer’s clefts and Maurer’s 
clefts tethers. Co-labeling immunofluorescence assays with MAHRP1 (resident Maurer’s cleft 
protein) and MAHRP2 (resident Maurer’s cleft tether protein) showed partial overlap of the 
signal indicating a partial localization of PF3D7_0702500-3xHA at Maurer’s clefts and tether 
structures (Figure 1E).  
The high-resolution subcellular localization of PF3D7_0702500-3xHA was determined by 
immunoelectron microscopy of ultrathin sections (Figure 2). PF3D7_0702500-3xHA was 
found to localize to electron-dense structures approximately 25 nm in diameter and 100 nm in 
length. They were found in proximity to Maurer’s clefts, tethers, and the iRBC membrane.  
In a solubility assay, PF3D7_0702500-3xHA was recovered in the hypotonic fraction 
indicating behavior as a soluble protein similar to GAPDH which was used as control (Figure 
1F, first and second panel). In contrast, the carbonate fraction contains peripheral membrane 
proteins, e.g. PFE1605w (Figure 1F, third panel), and in the Triton-X100 fraction integral 
membrane proteins such as MAHRP1 are found (Figure 1F, forth panel).  
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Interaction partners of PF3D7_0702500 
To identify interacting proteins of PF3D7_0702500 we performed co-immunoprecipitation 
(Co-IP) experiments of PF3D7_0702500-3xHA followed by mass spectrometry. Protein 
extracts of trophozoite PF3D7_0702500-3xHA iRBCs were analyzed. Potential interacting 
proteins of PF3D7_0702500-3xHA were eluted from α-HA-beads by competition with 
soluble HA peptide. As a negative control excess HA peptide was added to the protein extract 
during the binding step. Four sample replicates each were analyzed by mass spectrometry. 
The Δ value describes how enriched a protein was found in the sample compared to the 
negative control. We have identified a total number of 94 P. falciparum and human proteins 
positively enriched in the PF3D7_0702500-3xHA sample compared to the control sample 
(see Supplementary Table 2). Table 1 shows a list of 19 exported Plasmodium proteins 
identified in the Co-IP. We detected Maurer’s clefts proteins (e.g. MAHRP1, SBP1, REX1) 
and proteins localizing to the erythrocyte cytoskeleton (e.g. MESA, PFE1605w, PHISTb 
family proteins). Further, we found several human proteins localizing to the erythrocyte 
membrane and cytoskeleton proteins such as 55 kDa erythrocyte membrane protein, spectrin 
alpha and beta chain, ankyrin-1, band 4.1, band 7 and band 4.2 (Table 2). 
Colocalization analysis with confocal microscopy was performed to verify the potential P. 
falciparum interaction partners of PF3D7_0702500-3xHA. For MAHRP1, MAHRP2, 
Hsp70x, REX1, SBP1, MESA, PFE1605w, and PFI1780w specific antibodies were available. 
Additionally, the PF3D7_0702500-3xHA cell line was transfected to episomally overexpress 
PF3D7_0402000-GFP or PF3D7_0801000-GFP. These double transfected cell lines 
PF3D7_0702500-3xHA/PF3D7_0402000-GFP and PF3D7_0702500-3xHA/ 
PF3D7_0801000-GFP were used for colocalization studies using α-HA- and α-GFP-
antibodies. Huygens deconvolution and intensity-based colocalization analysis with the 
JACoP plugin identified PFI1780w, PF3D7_0402000-GFP and PF3D7_0801000-GFP as 
strongly colocalizing to PF3D7_0702500-3xHA with Pearson’s coefficients >0.9 and 
Maender’s coefficients >0.9 (Figure 3 A and B). In a next step, the double PF3D7_0702500-
3xHA/PF3D7_0402000-GFP and PF3D7_0702500-3xHA/ PF3D7_0801000-GFP cell lines 
were analysed by immunoelectron microscopy. No colocalization of PF3D7_0702500-3xHA 
and PF3D7_0402000-GFP or PF3D7_0702500-3xHA and PF3D7_0801000-GFP was 
observed. PF3D7_0402000-GFP was found at the iRBC cytoskeleton and PF3D7_0801000-
GFP at the iRBC cytoskeleton and at Maurer’s clefts (Supplementary Figure 1).  
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Phenotypical analysis of PF3D7_0702500 
To investigate the function of PF3D7_0702500 a knock out (KO) parasite line was generated 
using a CRISPR/Cas9 approach. A hDHFR resistance cassette was introduced to disrupt the 
gene and enable positive selection of transgenic parasites. The gene disruption was confirmed 
by PCR (Figure 4A) and Southern blot (data not shown).  
The PF3D7_0702500 KO was viable indicating that the respective gene is dispensable in 
culture. There was no significant growth difference between the PF3D7_0702500 KO cell 
line and wildtype 3D7 parasites (Figure 4B).  
Deformability of iRBC is important for the passage of iRBCs through small capillaries and to 
avoid clearance in the spleen. With microsphiltration cell deformability is assessed by 
mimicking the function of a spleen (Deplaine et al., 2011). We used highly synchronous 
parasite cultures in ring and trophozoite stages and the deformability measured by retention 
rates of the KO cell line was not significantly different to 3D7 infected iRBCs (Figure 4C).  
Similarly to deformability, the presentation of PfEMP1 on the iRBC surface is crucial for the 
parasite as it confers cytoadherence and allows avoidance of spleen passage. We measured 
cytoadherence to CD36 in semi-static binding in which the KO cell line was significantly 
reduced when compared to 3D7 (Figure 5A). CD36 binding depends on the expressed 
PfEMP1 variant and since no pre-selection of PfEMP1 expression was done before the 
experiments we determined the PfEMP1 repertoire expressed which was similar in both cell 
lines (Figure 5B). 
To verify that the reduced binding is not due to a lack of PfEMP1 on the iRBC surface, a 
trypsin cleavage assay was performed. In both cell lines PfEMP1 is present on the surface of 
the host erythrocyte (Figure 5C). Immunofluorescence assays with antibodies against the 
ATS-domain of PfEMP1 showed no difference in signal at the Maurer’s clefts indicating 
correct transport of PfEMP1 to the clefts (Figure 5D). However, it is not possible with this 
antibody to test the presence of PfEMP1 at the erythrocyte membrane.  
To further investigate the relationship between PF3D7_0702500 and PfEMP1, colocalization 
analysis of trophozoite PF3D7_0702500-3xHA and PfEMP1 (α-ATS antibody) was 
performed (Figure 5E). Partial overlap of the signals was observed. 
We have previously shown that MAHRP1 is essential for PfEMP1 presentation on the iRBC 
surface (Spycher et al., 2008). Therefore PF3D7_0702500 was endogenously 3xHA-tagged in 
a MAHRP1 KO cell line and the localization of PF3D7_0702500-3xHA was checked in a 
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PfEMP1 export depleted host cell.  PF3D7_0702500-3xHA localization was not affected by 
lack of PfEMP1 (Figure 5E).  
 
Discussion 
Within an approach of better understanding the role and interactions of exported proteins 
associated with Maurer’s clefts and Maurer’s clefts tethers, we have characterized the PNEP 
PF3D7_0702500 and suggest a function in anchoring PfEMP1 or facilitating PfEMP1 
transport from Maurer’s clefts to the iRBC membrane.  
To study PF3D7_0702500 in detail, a PF3D7_0702500-3xHA and a PF3D7_0702500 KO cell 
line were generated. The chosen CRISPR/Cas9 and combined CRISPR/Cas9–SLI approaches 
enabled the establishment of knock out and knock in cell lines in an efficient way.  
Endogenous PF3D7_0702500 3x-HA-tagging allowed us to study its expression and 
localization in the native environment (not overexpressed under an exogenous promoter). 
PF3D7_0702500-3xHA is present in the iRBC cytoplasm throughout the entire 
intraerythrocytic life cycle. The peak of PF3D7_0702500-3xHA expression seems during 
later life stages, putatively reflecting the importance of the protein in the second half of the 
red blood cell cycle.  
By immunoelectron microscopy we found PF3D7_0702500-3xHA localizing to electron 
dense structures. They resemble the uncoated vesicular-like structures (VLS) described before 
(Kriek et al., 2003, Wickert et al., 2003, Hanssen et al., 2008).  Uncoated VLS are spherical, 
and ~25-30nm in size, generally they are poorly defined.  Cyrklaff and colleagues observed 
vesicles in various sizes (20nm to >200nm) attached to actin filaments connecting Maurer’s 
clefts with the knobs and hypothesize that they may have a role in the transport of cargo 
(Cyrklaff et al., 2011). 
The solubility assay revealed soluble-protein-like behavior of PF3D7_0702500-3xHA. This is 
in line with its localization to non-membranous structures observed by electron microscopy. 
However, the TMHMM tool (Krogh et al., 2001, Sonnhammer et al., 1998) predicts a 
transmembrane domain between aa 32-50 in PF3D7_0702500. We suggest that the predicted 
transmembrane domain functions rather as signal peptide, as for PNEPs a hydrophobic N-
terminal region was described to be important as export element (Spielmann and Gilberger, 
2010). Previously we have shown that the predicted transmembrane domain of MAHRP2 
clearly is not a functional transmembrane domain (Pachlatko et al., 2010). This shows that the 
Characterization of PF3D7_0702500, an exported protein contributing to P. falciparum 
virulence 
 
44 
TMHMM tool is a prediction program only and that additional experiments are needed to 
confirm its predictions. 
Alternatively, PF3D7_0702500 aa 48-52 (KYIRS) could be a non-canonical, so far unknown 
PEXEL variant (Schulze et al., 2015). A putatively cleaved PF3D7_0702500 would have a 
molecular weight of around 22kDa. Thus one could hypothesize that the observed 40kDa 
band on the Western blot (Figure 1B) corresponds to a dimer of the protein. 
We suggest a shuttling function of PF3D7_0702500 containing structures between Maurer’s 
clefts and the iRBC membrane. The identification of putative interaction partners resident to 
both structures supports this thesis. Of the 18 exported proteins that are possibly interacting 
with PF3D7_0702500-3xHA, 7 have been described to be involved in trafficking or 
anchoring PfEMP1 to the iRBC surface: MAHRP1 (Spycher et al., 2008), SBP1 (Cooke et al., 
2006), REX1 (McHugh et al., 2015), Hsp70-x (Charnaud et al., 2017), PFE1605w (Oberli et 
al., 2016), PTP5 and PTP6 (Maier et al., 2008). Further, we could validate a previously found 
MAHRP2 interaction with PF3D7_0702500 (unpublished), since we identified MAHRP2 in 
the immunoprecipitation with PF3D7_0702500.   
Following up the putative interaction partners we narrowed down the candidates for direct 
interaction by confocal microscopy followed by colocalization analysis. PFI1780w, 
PF3D7_0801000-GFP and PF3D7_0402000-GFP were identified in close proximity of 
PF3D7_0702500-3xHA. All of them belong to the Plasmodium Helical Interspersed 
Subtelomeric (PHIST) protein family (reviewed in Warncke et al., 2016). PFI1780w belongs 
to the PHISTc subfamily, its function is unknown. It has been shown to interact with the ATS 
domain of PfEMP1 in vitro (Mayer et al., 2012) and localizes to the iRBC periphery with 
ATS (Oberli et al., 2014). However, it is not co-transported with PfEMP1 (Oberli et al., 
2014). PF3D7_0801000 also belongs to the PHISTc subfamily and is a soluble protein present 
in the PV lumen, the iRBC cytosol and localizes to J-dots. The P. yoellii orthologue 
PcyPHIST/CVC-8195 localizes to caveola-vesicle complex (CVC) structures that are not 
produced in P. falciparum (Akinyi et al., 2012). PF3D7_0402000 is a PHISTa subfamily 
protein that has been reported to interact with the human cytoskeleton protein band 4.1R 
(Parish et al., 2013). It is noteworthy that a Co-IP using the ATS domain of var2CSA 
identified PF3D7_0702500 and PF3D7_0801000 (unpublished) suggesting a complex of 
these three proteins. In contrast, immunoelectron microscopy did not confirm a close physical 
association of PF3D7_0702500-3xHA neither with PF3D7_0402000-GFP nor 
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PF3D7_0801000-GFP. PF3D7_0402000-3xHA was found at the cytoskeleton. 
PF3D7_0801000-GFP localized to Maurer’s clefts and the cytoskeleton but not to the 
PF3D7_0702500-3xHA-labelled electron-dense structures (Supplementary Figure 1). Thus, it 
is rather unlikely that there is a direct interaction of the two proteins, however a function in 
the same complex (e.g. an indirect interaction) cannot be excluded. 
Phenotypical analysis of the PF3D7_0702500 KO cell line revealed reduced binding to the 
endothelial receptor CD36. Binding capacity of iRBCs to different receptor molecules 
depends on the PfEMP1 variant that is expressed in parasite culture. To exclude that the 
observed reduced binding of the PF3D7_0702500 KO cell line is due to a different 
dominantly expressed PfEMP1 variant, var gene expression analysis was performed. In line 
with our previous observations, the most dominantly expressed PfEMP1 variant was 
PF07_0048 in both cultures which belongs to the upsC group. PF07_0048, PFD0615c, 
PFL1955w, PFD0625c, and MAL6P1.252, the most frequently expressed PfEMP1 variants in 
both cultures are CD36 binders (Robinson et al., 2003, Oberli et al., 2016). We found 
PfEMP1 correctly surface-presented in a PF3D7_0702500 KO trypsin cleavage assay and the 
Western blot does not explicitly indicate a reduced amount of (cleaved) PfEMP1 in 
PF3D7_0702500 KO compared to wildtype. However, the quantification of PfEMP1 
molecules transported to the surface in order to find out whether PF3D7_0702500 plays a role 
in efficient PfEMP1 delivery will be challenging. Preliminary evidence for an interaction of 
PF3D7_0702500-3xHA and PfEMP1 in the erythrocyte cytosol was obtained by confocal 
colocalization analysis. Further analysis of the electron-dense structures PF3D7_0702500-
3xHA localizes to will hopefully give more insights whether they are involved in PfEMP1 
shuttling.  
Another possible explanation of the reduced CD36 binding of PF3D7_0702500 KO iRBCs is 
a defective anchoring of PfEMP1 in the erythrocyte membrane. In other instances PFE1605w 
has been shown to comigrate with PfEMP1 but not to be involved in PfEMP1 transport. The 
reduced binding to CD36 (but not to other endothelial receptors) upon PFE1605w knock 
down was explained by different interactions of PFE1605w with various PfEMP1 molecules 
(Oberli et al., 2016). Additional binding assays with preselected PF3D7_0702500 KO and 
wildtype iRBCs binding to CSA, ICAM-1, or EPCR could clarify the PfEMP1 variant 
specificity of PF3D7_0702500.  
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In conclusion, we characterized the PNEP PF3D7_0702500 and suggest a function in efficient 
delivery or anchoring of PfEMP1 to the iRBC surface. The complete understanding of 
PfEMP1 transport to the iRBC surface will enable new approaches in fighting this devastating 
pathogen.  
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Figure legends  
Figure 1: PF3D7_0702500-3xHA is expressed throughout the intraerythrocytic life cycle. 
A: Schematic representation of endogenous tagging strategy using a combined CRISPR/Cas9-
SLI approach. 5’ and 3’ homology regions (HRs) flank an integration cassette consisting of 
the tag (e.g. 3xHA), a 2A skip peptide, a blasticidine (bsd) resistance including a terminator. 
On the same plasmid, the Cas9 and the gRNA are included. The black arrow indicates the 
gRNA recognition site close to the 3’ terminus of the gene of interest.  Not drawn to scale. B: 
Western blot analysis of 3D7 and PF3D7_0702500-3xHA saponin lysates. The membranes 
were probed with HA antibody and GAPDH antibody as loading control. C: Time course 
immunofluorescence assay. Scale bar 2µm. D: Time course Western blot analysis of 
PF3D7_0702500-3xHA expressing parasites. The membrane was probed with HA antibody 
and GAPDH antibody as loading control. E: Co-labelling immunofluorescence assay of 
PF3D7_0702500-3xHA with MAHRP1, and MAHRP2 respectively. Scale bar 2µm. F: 
Western blot analysis from PF3D7_0702500-3xHA solubility assay. Membranes were probed 
with HA, GAPDH, PFE1605w, and MAHRP1 antibodies. Lanes represent hypotonic lysis 
fraction, Na2CO3 fraction, Triton X-100-soluble fraction, and the remaining insoluble 
fraction. 
 
Figure 2: PF3D7_0702500-3xHA localizes to electron-dense structures. Immunoelectron 
microscopy of iRBCs expressing PF3D7_0702500-3xHA. Small 5nm gold conjugated Protein 
A indicating α-HA antibody (arrow), large 10nm gold conjugated Protein A decorating α-
MAHRP2 antibody (triangle). Knobs (K), Maurer’s clefts (MC), and Maurer’s clefts tethers 
(T) are indicated. Scale bar 500nm (A), 200nm (B).  
 
Figure 3: Colocalization of PF3D7_0702500-3xHA with PF3D7_0801000-GFP, 
PF3D7_0402000-GFP, and PFI1780w (PF3D7_0936800-GFP). A: Confocal microscopy 
pictures of PF3D7_0801000-GFP, PF3D7_0402000-GFP, and PFI1780w (PF3D7_0936800-
GFP) colocalization analysis with PF3D7_0702500-3xHA. Scale bar 2µm.  B: Table of 
Pearson’s coefficient, and Maenders’ coefficients.  M1 indicates the fraction of 
PF3D7_0801000-GFP/PF3D7_0402000-GFP/PFI1780w (PF3D7_0936800-GFP) overlapping 
with PF3D7_0702500-3xHA, M2 indicates the fraction of PF3D7_0702500-3xHA  
overlapping with PF3D7_0801000-GFP/PF3D7_0402000-GFP/PFI1780w (PF3D7_0936800-
GFP).   
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Figure 4: Phenotypical analysis of PF3D7_0702500 KO. A: A PF3D7_0702500 KO cell 
line was generated by CRISP/Cas9 replacing the gene of interest with a hDHFR resistance 
cassette. Correct integration of the hDHFR cassette was assessed by PCR spanning the 
integration sites. Expected PCR product sizes are for 3D7 no product, for PF3D7_0702500 
KO 642bp for 5’HR, 883bp for 3’HR. B: Growth assay of 3D7 wild type and 
PF3D7_0702500 KO iRBCs. C: Deformability assay of tightly synchronized 3D7 wild type 
and PF3D7_0702500 KO ring and trophozoite iRBCs. Shown are retention rates and standard 
deviations of means of 6 replicates. 
 
Figure 5: PF3D7_0702500 KO shows impaired virulence. A: Semi-static CD36 binding 
assay. Shown is the mean of relative binding of trophozoite 3D7 and PF3D7_0702500 KO 
iRBCs to CD36 of 3 biological replicates. Error bar shows standard deviation. B: Pie charts 
show the PfEMP1 transcript distribution in the 3D7 wildtype and PF3D7_0702500 KO cell 
line. Each color represents a different PfEMP1 variant. C: Western blot analysis of trypsin 
cleavage assay of 3D7 wildtype and PF3D7_0702500 KO iRBCs. –T is negative control, +T 
is sample with added trypsin. The membrane was probed with ATS-antibody. D: PfEMP1 
immunofluorescence assay (ATS antibody) of 3D7 and PF3D7_0702500 KO iRBCs. Scale 
bar 2µm. E: Immunofluorescence assay of PF3D7_0702500-3xHA in wildtype and MAHRP1 
KO background. Scale bar 2µm.  
 
Supplementary Figure 1: Immunoelectron microscopy of PF3D7_0702500-3xHA with 
PF3D7_0402000-GFP and PF3D7_0801000-GFP. A: PF3D702500-3xHA/ 
PF3D7_0402000-GFP expressing cell line with small 5nm gold conjugated Protein A 
indicating α-GFP antibody (triangle), large 10nm gold conjugated Protein A decorating α-HA 
antibody. B: PF3D702500-3xHA/PF3D7_0801000-GFP expressing cells with small 5nm gold 
conjugated Protein A indicating α-GFP antibody (triangle), large 10nm gold conjugated 
Protein A decorating α-HA antibody. Scalebar 1µm. 
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Introduction 
Host cell cytoskeleton remodeling by the parasite P. falciparum contributes significantly to its 
virulence and persistence in the human red blood cell. A large number of exported parasite 
proteins interact with the host cytoskeleton. MESA (PfEMP2, PF3D7_0500800) was one of 
the first described parasite proteins to associate to the inside of the iRBC membrane (Coppel 
et al., 1986, Howard et al., 1988). It contains a PEXEL motif, which is functional in 
combination with an embedded signal peptide to direct the protein to the RBC cytosol (Black 
et al., 2008). MESA is expressed in trophozoite and schizont stages of the asexual red blood 
cell cycle (Coppel et al., 1988). 
The 168kDa protein has a 19-residue region near the N-terminus binding to the erythrocyte 
membrane skeletal protein band 4.1 (Lustigman et al., 1990, Bennett et al., 1997, Kun et al., 
1999). This motif is also known as MEC motif (MESA erythrocyte cytoskeleton binding, 
Kilili and LaCount, 2011) and present in several other exported P. falciparum protein (e.g. 
some PHISTb family members), putatively targeting them to the erythrocyte cytoskeleton 
(Warncke et al., 2016).  
In vitro studies with recombinant MESA and band 4.1 revealed competition between the 
human phosphoprotein p55 that regulates plasma membrane stability (Chishti, 1998), and 
MESA for band 4.1 interaction (Lustigman et al., 1990, Waller et al., 2003). Band 4.1 that 
interacts with spectrin and actin is crucial for the cytoskeleton deformability. Further, band 
4.1 ensures mechanical stability of the RBC by connecting the cytoskeleton to the membrane 
via glycophorin C. Interestingly, MESA accumulates in the erythrocyte cytosol of band 4.1 
deficient erythrocytes and the iRBCs show poor survival (Magowan et al., 1995). Unbound 
MESA thus seems detrimental or even toxic to the host erythrocyte. The relationship between 
band 4.1 and MESA could reflect a structural function of MESA in modulating the protein 
interactions in the host cytoskeleton in order to facilitate parasite survival (Waller et al., 
2003).  
Phosphorylation is a prevalent post-transcriptional modification of RBC cytoskeleton proteins 
to regulate mechanical properties of the RBC cytoskeleton. MESA is also a phosphoprotein, 
the phosphorylation sites have been predicted (Collins et al., 2014). It was found that the 
kinase responsible for MESA phosphorylation is probably shared with the band 4.1 
phosphorylating kinase and is sensitive to casein kinase inhibitors (Magowan et al., 1998). 
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MESA was also discussed as a diagnostic marker as it was found in malaria patient serum by 
mass spectrometry analysis (Zainudin et al., 2015). Further, in a mass-spectrometry-based  
proteomic approach it was identified as overexpressed in samples from patients with cerebral 
malaria compared to uncomplicated malaria samples. This may indicate an association of 
MESA with the pathophysiology of cerebral malaria (Bertin et al., 2016). 
We have identified MESA in a MAHRP2 co-immunoprecipitation experiment aiming at the 
identification of Maurer’s clefts tether interacting proteins (unpublished). MESA is a well-
known protein localizing to the erythrocyte cytoskeleton, but no specific function has been 
assigned to it yet. It has been hypothesized that MESA has a structural role in remodeling the 
host cell, thus putatively interfering with the iRBC deformability. Here, we endogenously 
GFP-tagged MESA in order to identify interaction partners of the protein by 
immunoprecipitation experiments. Further we generated a 5’ MESA knock out (KO) parasite 
cell line for functional analysis of the protein. We assessed growth, deformability and 
cytoadherence properties of the knock out cell line but were not able to assign a function to 
the protein nor were we able to describe a distinct phenotype in the knock out cell line. 
 
Methods 
Cell culture and transfections 
P. falciparum 3D7 was cultured and transfected as described (Moll et al., 2013). For positive 
selection of transfected parasites 10nM WR99210 (Jacobs Pharmaceuticals, Cologne, 
Germany), and 5mg/ml blasticidin (Sigma-Aldrich, Inc.) were used. 
 
Plasmid constructs  
The endogenous MESA-GFP tagged cell line was generated using a combined CRISPR-
Cas9/SLI approach (Ghorbal et al., 2014, Birnbaum et al., 2017). Homology regions between 
300-1000bp were designed, and a gRNA was chosen with the CHOPCHOP software (Labun 
et al., 2016, Montague et al., 2014). Mutations of the gRNA recognition sequence were 
introduced by gene synthesis (GenScript, USA) of the containing homology region in order to 
avoid recleavage of the successfully tagged endogenous gene. The homology regions and 
gRNA were PCR amplified using primers listed in Table 1 and cloned into 
pCRISPR_GFP2ABSD using the In-Fusion® HD Cloning Kit (Clontech® Laboratories, 
Inc.). pCRISPR_GFP2ABSD contains the Cas9, the gRNA within the gRNA scaffold, and the 
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integration cassette flanked by the 5’ and 3’ homology regions. The integration cassette 
consists of the GFP-tag and a bsd selection marker separated by a 2A skip peptide (Szymczak 
et al., 2004) and followed by a terminator. The selection marker lacks a promotor and can 
only be expressed after successful integration into the target locus. The skip peptide triggers a 
ribosomal skip mechanism and thus impairs normal peptide bond formation preventing the 
attachment of the selection marker to the target protein (Donnelly et al., 2001).  
The single cross-over MESA KO cell line was generated with the pH plasmid including a 5’ 
stretch of the MESA gene. The homology region was PCR amplified using the primers listed 
in Supplementary Table 1 and cloned with EcoRI and BamHI into the plasmid.  
 
Western blot analysis 
Parasite saponin lysates were run on 4-12% Bis/Tris precast gels (NuPAGE®, Life 
Technologies) according to the manufacturer’s protocol. Protein transfer was performed with 
the iBlot 2.0 (Life Technologies). Subsequently, the membrane was blocked with 10% 
skimmed milk/TNT (100mM Tris, 150mM NaCl, 0.1% Tween) and probed with the first 
antibody in 3% skimmed milk/TNT at room temperature for 2h-O/N. After 6 washes for 5min 
with TNT the secondary antibody conjugated to HRP was incubated in the respective dilution 
in 3% skimmed milk/TNT for 2h at room temperature. After another 6 washes for 5min with 
TNT the signal was detected by Super Signal West Pico Chemiluminescent Substrate 
(Thermo Scientific) or LumiGlo Reserve Chemiluminescent Substrate (Seracare) according to 
the manufacturer’s protocol. The antibodies used were: mouse α-GFP (Roche, 1:250), mouse 
α-GAPDH (1:20’000), goat α-mouse-HRP (Pierce, 1:5000). 
 
Immunofluorescence Assay 
Thin blood smears of parasite cultures were fixed in ice-cold 60% methanol/40% acetone for 
2min. After air-drying of the smear, a small well was drawn with a hydrophobic pen and the 
respective area was blocked with 3% BSA/PBS for 1h at room temperature in a humidified 
chamber. Then, the cells were incubated with mouse α-GFP (Roche, 1:100), rabbit α-MESA 
(1:200), rabbit α-RESA (1:200), rabbit α-MAHRP2 (1:100), mouse α-PFI1780w (1:1000), 
rabbit α-PFE1605w (1:100), rabbit α-band 4.1 (Abcam, 1:100), and rabbit α-spectrin (Abcam, 
1:100)  in 3% BSA/PBS for minimum 2h at room temperature in a humidified chamber. After 
3 washes with 3% BSA/PBS for 7min the secondary antibody (goat α-mouse Alexa488, goat 
Functional characterization of the Plasmodium falciparum mature erythrocyte surface antigen 
(MESA) 
 
69 
α-rabbit Alexa488, goat α-rabbit Alexa568, goat α-rat Alexa568; all Invitrogen, 1:200) was 
applied in the appropriate dilution in 3% BSA/PBS for minimum 1h at room temperature in a 
humidified chamber. After another 3 wash steps with 3% BSA/PBS for 7min each, a coverslip 
was mounted with 2µl VECTASHIELD® with DAPI (Vector Laboratories Inc.). For imaging 
a 63x oil-immersion lens (1.4 numerical aperture) on a Leica 5000 B microscope was used. 
The images were obtained by using the software Leica ApplicationSuite 4.4. and analyzed 
using Fiji (Schindelin et al., 2012). 
 
Erythrocyte Cytoskeleton Imaging 
First, coverslips were functionalized to prepare erythrocyte binding (Aebersold et al., 1986). 
To this end the coverslips were cleaned with Ethanol and ddH2O and dried with compressed 
air. Then, the coverslips were immersed for 60sec in 2% 3-Aminopropyltriethoxysilane 
(Pierce)/dry acetone (Sigma) at room temperature. Subsequently, the coverslips were rinsed 
with acetone and air dried. 300µl fresh 1mM BS3 cross linker (Pierce)/PBS was placed on the 
surface of each silyated coverslip and incubated for 30min at room temperature. Then, the 
coverslips were washed 3 times with 300µl PBS. Next, 300µl 0.1mg/ml Erythroagglutinating 
phytohemoagglutinin (PHA-E, EY-Labs/Lubio) were applied on the silyated-BS3-coupled 
coverslip and incubated for 1-2h at room temperature in a humidified chamber. After rinsing 
the coverslips 3 times with PBS, they were incubated in 0.1M Glycine/PBS for 15min at room 
temperature. After another 3 washes with PBS, binding and shearing of erythrocytes was 
performed as published (Shi et al., 2013). In brief, 150µl of 4% hematocrit iRBCs/PBS were 
pipetted on the activated coverslip and allowed to adhere for 1-3h at 37°C in a humidified 
chamber. To shear and lyse the iRBCs a 10ml syringe with a 23G needle was used to flush the 
cells on the coverslip with 5P8-10 buffer (5mM Na2HPO4/NaH2PO4, 10mM NaCl, pH8) from 
a 20° angle 3 times. The coverslip was washed twice with ddH2O before proceeding with an 
immunofluorescence assay.  
 
Co-immunoprecipitation  
150ml synchronized parasite culture was harvested by Percoll purification to enrich late stage 
parasites. Proteins were cross-linked with 1% formaldehyde in culture media for 30min on a 
rotator at 37°C. Cross-linking was stopped by adding glycine to a final concentration of 0.3M. 
The red blood cells were subsequently lysed with 0.03% saponin for 10min at 4°C. 
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Afterwards the pellet was resuspended in sonication buffer (10mM Tris-HCl pH 8, 0.5mM 
EDTA, 0.2% SDS, cOmplete protease inhibitor cocktail (Roche)) and sonicated for 15min (30 
sec on/30 sec off) in a Bioruptor UCD-300. Western blot analysis was performed to confirm 
the soluble fraction to contain the protein of interest. For the co-immunoprecipitation the 
sample and the control were divided into 4 replicates each. 350µl sonication supernatant was 
mixed with 350µl dilution buffer (10mM Tris-HCl pH 7.4, 150mM NaCl, 0.5 mM EDTA, 
0.5% Nonidet 40, cOmplete protease inhibitor cocktail (Roche)). Samples were mixed with 
25µl GFP-Trap®_MA Magnetic Agarose Beads (Chromotek) and incubated at 4°C and 
25rpm overnight. Then, beads were pelleted with a magnet and washed 4 times with dilution 
buffer. Finally, the beads were mixed with 30µl 4x LDS sample buffer (Invitrogen) and boiled 
10min at 95°C. The supernatant was collected as elution. The fractions were analyzed by 
Silver Gel (SilverQuest, Invitrogen) and Western blot before mass spectrometry analysis. 
 
MS sample preparation 
Samples were loaded onto a 4%-12% gradient Bis-Tris gel (Thermo) and run in 1x MOPS 
buffer at 180V for 10min. Each lane was sliced, minced and transferred to an Eppendorf 
reaction tube. In gel digest was performed as previously described (Bluhm et al., 2016) and 
samples stored on StageTips (Rappsilber et al., 2007) until measurement. Alternatively, for 
biotin proximity ligation experiments, the beads were directly incubated in 2mM DTT/50mM 
ammonium bicarbonate buffer (Sigma-Aldrich) and subsequently alkylated with 5mM 
iodoacetamide (Sigma-Aldrich). Digestions were performed with 200ng of trypsin (Sigma-
Aldrich) in 2M urea/50mM ammonium bicarbonate buffer at room temperature overnight. 
Tryptic peptides were stored on StageTips (Rappsilber et al., 2007) until measurement. 
 
MS measurement 
The digested peptides of the samples were separated on a 25-cm reverse-phase capillary 
(75µM inner diameter, New Objective) packed with Reprosil C18 material (Dr. Maisch 
GmbH). Elution of the peptides was achieved with a 2h gradient from 2%-40% Buffer 
acetonitrile followed by a 95% acetonitrile wash-out at 200nl/min on an Easy LC1000 HPLC 
system (Thermo). Mass spectrometry measurements were performed with a Q Exactive Plus 
mass spectrometer (Thermo) operated with a Top10 data-dependent MS/MS acquisition 
method per full scan. Spray voltage was set to 2.2-2.4kV. 
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MS data analysis 
MS raw data was analyzed using MaxQuant v1.5.2.8 (Cox and Mann, 2008) with standard 
settings and activated match between runs and LFQ quantitation features. The search was 
performed against a Human Uniprot database (81,194 entries) and the Plasmodium falciparum 
PlasmoDB 9.3 database (5,538 entries). The proteinGroups file was filtered for known 
contaminants and reverse hits prior to statistical analysis (Welch t-test). Data was plotted 
using the R environment. 
 
Southern blot 
Genomic DNA was isolated by phenol/chloroform extraction of saponin lysed parasites. 
gDNA was digested with AflIII & AflII restriction enzymes, separated on a 0.8% agarose gel 
and transferred onto a Amersham Hybond-N+ membrane (GE Healthcare). Blots were probed 
with 
32
P-dATP-labelled probe fragments. As probe, the 5’ stretch MESA homology region of 
the pH-MESA KO plasmid was used.  
 
Growth assay 
Asynchronous parasite cultures were set up at 0.2% parasitemia. Parasitemia was determined 
by flow cytometry and followed over 5 days. Parasites were stained with SYBR® Green I 
nucleic acid gel stain (Sigma-Aldrich) 1:5000 for 20min at 37°C in the dark, washed 3x with 
culture medium and 100’000 cells were assessed with a BD FACSCalibur. The experiment 
was performed in biological triplicates, standard deviations were calculated and exponential 
curves fitted to the data points. 
 
Binding assay 
Semi-static binding assays were performed as published before (Oberli et al., 2016). 100µl 
50µg/ml human CD36 recombinant protein (Sino Biological, China) was applied into wells of 
eight-chamber cell culture glass slides (Falcon, Big Flats, NY, USA) and incubated overnight 
at 4°C to allow proteins to absorb to the surface. The wells were blocked with 1% BSA/PBS 
for 1h at 37°C. Parasite cultures were washed twice with RPMI-HEPES and spotted onto the 
immobilized CD36 and cultured for 2h under continuous and simultaneous shaking (140 rpm, 
proBlot 25 Rocker; Labnet International Inc., NY, USA) (105 rpm, Lab-Therm LT-W, 
Kühner, Switzerland) at 37°C. Non-bound erythrocytes were removed by six gentle washes 
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with RPMI-HEPES with simultaneous shaking for 2min. Bound iRBCs were fixed with 2% 
glutaraldehyde in RPMI-HEPES overnight, stained with 10% Giemsa for 1h and 
microscopically counted. Results are shown as mean number of parasites bound per square 
millimeter and normalized to 1% parasitemia. The experiment was performed in biological 
triplicates. 
 
Microsphiltration 
Microsphiltration experiments were performed as described in Lavazec et al. (2013). Tightly 
synchronized parasite cultures (600µl, 0.5-10% parasitemia, 1.5% hematocrit) were passed 
under flow (60ml/h) through a microsphere matrix consisting of solder powder beads from 5-
15µm and 15-25µm diameter (Industrie des Poudres Sphériques, Annemasse, France). After 
rinsing the column with 5ml of culture medium, parasitemia of input and flow-through 
samples were assessed by flow cytometry. Parasites were stained with SYBR® Green I 
nucleic acid gel stain (Sigma-Aldrich) 1:5000 for 20min at 37°C in the dark, washed 3x with 
culture medium and 100’000 cells were assessed with a BD FACSCalibur. All experiments 
were performed in technical triplicates. Retention rates were calculated as 1−(parasitemia 
flow through sample/parasitemia input sample). 
 
Scanning electron microscopy 
For scanning electron microscopy mature parasites were knob-selected, purified by Percoll 
density gradient and fixed in 2.5% PBS for 1 hour at room temperature. After transfer to 
coverslips preliminary coated with Poly-L-lysine, the samples were dehydrated in increasing 
concentration of ethanol (10% v/v, 25% v/v, 50% v/v, 75% v/v, 90% v/v and 2 x 100% v/v, 
10min each), critical point dryed and finally sputtered with 5nm Platinum (LEICA EM 
ACE600). The micrographs were taken with a SEM Versa 3D (FEI) at 5kV. 
 
Results 
Expression and localization of MESA 
We generated a cell line with endogenously tagged MESA as a tool for protein 
characterization. To that end, a CRISPR/Cas9-SLI approach was used to introduce a GFP-tag 
at the MESA C-terminus. Correct integration of the tag-cassette was checked by PCR (data 
not shown). MESA-GFP protein expression was confirmed by Western blot and 
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immunofluorescence analysis (Figure 1A and B). In Western blot analysis no GFP was 
detected in the 3D7 control. The MESA-GFP signal runs higher (>250kDa) as its calculated 
molecular weight of 202kDa. In immunofluorescence microscopy the signal of both MESA 
antibody and GFP antibody localize to the iRBC periphery (Figure 1B). 
To confirm published expression data of MESA, Western blot and immunofluorescence 
analysis throughout the intraerythrocytic life cycle were performed (Figure 1C and D). As the 
MESA antibody is not suitable for Western blot analysis, Western blot was performed with 
MESA-GFP parasites, and immunofluorescence analysis with 3D7 wildtype and MESA-GFP 
(data not shown) parasites. We found MESA expression as expected in the second half of the 
intraerythrocytic life cycle in trophozoite and schizont stages.  
MESA localizes to the cytoskeleton of iRBCs (Coppel et al., 1988) and is not surface exposed 
as the name misleadingly indicates. In fluorescence microscopy we observe MESA at the 
periphery of red blood cells (Figure 1B and D). We performed cytoskeleton imaging where 
the inside of RBCs can be investigated by immunofluorescence assay after the cells were 
bound to a glass slide and opened with shear stress. The cytosolic face of the membrane and 
attached cytoskeleton is exposed on the surface of the glass slide. By immunofluorescence 
imaging MESA was identified specifically in iRBCs (Figure 1E). Glycophorin A/B staining 
serves as control for shearing of the RBCs; if the cells were not open, the stain would cover 
all the area and not only label the contours of the cells. 
 
Interaction partners of MESA 
To identify putative interacting proteins of MESA-GFP co-immunoprecipitation with α-GFP 
beads (GFP-trap, Chromotek) followed by mass spectrometry was performed. MESA-GFP 
protein extracts of trophozoite stages were analyzed, as negative control 3D7 wildtype 
parasites were used.  We have identified a total number of 53 proteins positively enriched in 
the MESA-GFP compared to the control sample (see Supplementary Table 2). Among those 
were several exported Plasmodium (Table 1) and human (Table 2) proteins.   
In order to confirm association of MESA with candidates from the co-immunoprecipitation 
experiment, co-labelling fluorescence imaging analysis was performed.  
For Plasmodium proteins we used antibodies against GFP or MESA combined with 
PFE1605w or PFI1780w, in MESA-GFP or 3D7 cell lines. Additionally, a cell line 
episomally expressing PF3D7_0424600-GFP was probed with MESA and GFP antibodies 
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(Figure 2A). Limited overlap with the MESA signal was observed with PFE1605w and 
PFI1780w, but significant overlap was seen with another PHISTb protein, PF3D7_0424600-
GFP, and MESA. 
For human interaction candidates, we used the MESA-GFP cell line and co-labelled with 
GFP, band 4.1, and spectrin antibodies (Figure 2B). We found a good overlap of the GFP 
signal with band 4.1 or the spectrin signals. 
 
Functional analysis of MESA 
In order to investigate protein function, a MESA KO cell line was generated by single cross-
over homologous recombination. A hDHFR resistance cassette was introduced to disrupt the 
gene and enable positive selection of transgenic parasites. Successful knock out was 
confirmed by PCR (data not shown) and Southern blot (Figure 3A). There is some residual 
plasmid in the MESA KO parasite cell line, which is usually lost over the course of several 
generations.  The MESA KO was viable indicating that the respective gene is dispensable. We 
assessed growth of the MESA KO compared to wildtype 3D7 and found no significant growth 
difference (Figure 3B).  
To check whether MESA has an influence on PfEMP1 presentation and anchorage on the 
iRBC membrane, we performed a semi-static binding assay to CD36 (Figure 3C). We found 
MESA KO have similar binding to CD36 as 3D7.  
Further, we assessed deformability of MESA KO by microsphiltration (Figure 3D). With that 
method, cell deformability is assessed by passing cells under flow through a microsphere 
matrix consisting of different-sized beads mimicking the cell passage through the spleen. Less 
deformable cell are more prone to be retained in the matrix, flexible cells can pass the matrix 
easily. The experiments were performed with highly synchronous parasite cultures at different 
time points in the life cycle stage (22hpi, 28hpi, 34hpi and 40hpi). Retention percentages of 
45.8±8.7%, 71.5±17.7%, 72.1±8.4%, 86.7±3.7% for 3D7 and 51.6±13.1%, 68.1±9.0%, 
70.7±9.8%, 90.6±6.9% for MESA KO at 22hpi, 28hpi, 34hpi and 40hpi  were observed, 
respectively (see Figure 3D). In summary, no significant differences in retention rates 
between MESA KO and 3D7 wildtype were found.  
MESA localizes to the erythrocyte cytoskeleton close to knob structures. With scanning 
electron microscopy we investigated morphology of knobs in MESA KO iRBCs (Figure 3E). 
No obvious difference in the appearance of MESA KO and 3D7 iRBCs was noted. 
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We have previously identified MESA in MAHRP2 co-immunoprecipitation experiments 
(unpublished). Therefore we performed an immunofluorescence assay with MESA KO cells 
to investigate MAHRP2 localization (Figure 4A). We found no aberrant localization of 
MAHRP2 in MESA KO compared to 3D7 wildtype. 
RESA (ring infected erythrocyte surface antigen, PF3D7_0102200) localizes to the 
erythrocyte cytoskeleton in ring stage infected RBCs until approximately 24 hours post 
infection (Brown et al., 1985). MESA localizes to the erythrocyte cytoskeleton in the second 
half of the parasite lifecycle and interacts with band 4.1 (Bennett et al., 1997). We inquired 
whether MESA has a role in replacing RESA and therefore tested the (timed) presence of 
RESA in MESA KO iRBCs with an immunofluorescence assay (Figure 4B). By comparing 
RESA and MESA expression in ring and trophozoite stages of MESA KO and 3D7 wildtype 
respectively we found no difference. 
 
Discussion 
Many P. falciparum proteins are exported to the host erythrocyte and localize to the 
cytoskeleton. Their functions are diverse, e.g. stabilizing the cytoskeleton (RESA, Mills et al., 
2007), contributing to the stability of the major virulence complex (PFE1605w,  Oberli et al., 
2016), or establishing NPPs (Nguitragool et al., 2011). However, many protein functions of 
exported P. falciparum proteins are not understood. We aimed at assigning a function to 
MESA, a long known protein residing at the erythrocyte cytoskeleton. 
We successfully generated an endogenous C-terminally tagged MESA-GFP cell line by a 
combined CRISPR/Cas9-SLI approach. This gene editing strategy facilitates and accelerates 
genome manipulation greatly. On one hand, targeted DNA double strand breaks (with the 
help of a sequence-specific gRNAs) and customized sequence adjustments are introduced in 
the genome through the provided repair templates. On the other hand, the introduction of a 
resistance cassette separated from the gene of interest by a skip-peptide enables positive 
selection of transgenic parasites immediately after transfection thanks to the fast action of the 
CRISPR/Cas9 editing system.  
MESA expression in trophozoite/schizont stages and MESA localization to the inner side of 
the iRBC membrane was confirmed in 3D7 wildtype and MESA-GFP transgenic parasite cell 
lines (Coppel et al., 1988). In cytoskeleton imaging iRBCs cannot be distinguished from 
uninfected RBCs by (parasite) nuclear staining. MESA is a suitable marker for this method as 
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it is strongly bound to the erythrocyte cytoskeleton and resistant to the harsh shearing 
conditions. 
In order to identify interaction partners of MESA-GFP co-immunoprecipitation experiments 
were performed. From 4 independent replicates 8 PHIST family proteins were detected, from 
which 6 (PF3D7_0532400 PF3D7_1102500, PF3D7_0102200, PF3D7_0731300, 
PF3D7_1201000, and PF3D7_0424600) belong to the PHISTb subfamily. To our current 
knowledge, all members of this subfamily localize at the host cytoskeleton (Foley et al., 1991, 
Florens et al., 2004, Tarr et al., 2014, Proellocks et al., 2014, Warncke et al., 2016). 
PF3D7_0936800 localizes at the host cell membrane (Oberli et al., 2014). PF3D7_0501100 is 
a Hsp40 type II co-chaperone (Kulzer et al., 2010, Petersen et al., 2016) and Hsp70x is an 
Plasmodium exported chaperone (Kulzer et al., 2012). Hsp70/Hsp40 complexes are suggested 
to be involved in facilitating protein trafficking and targeting other proteins to their 
destination (Kampinga and Craig, 2010). MESA is a Triton X-100 insoluble protein (Coppel 
et al., 1988) that cannot simply diffuse through the RBC cytoskeleton as soluble proteins do. 
Thus it is conceivable that its transport is chaperone-assisted.  
We also identified several human cytoskeleton or membrane associated proteins as expected 
regarding the localization of MESA-GFP. The previously reported MESA interaction partner 
band 4.1 (Bennett et al., 1997) as well as the MESA opponent p55 (55 kDa erythrocyte 
membrane protein) (Waller et al., 2003) were enriched in the MESA-GFP sample. 
Interestingly, MAHRP2 was not identified in our co-immunoprecipitation experiments, thus 
the MAHRP2 co-immunoprecipitation could not be complemented. MESA seems a very 
abundant protein which may contribute to the finding that we identify it almost in every 
immunoprecipitation experiment.  
By immunofluorescence assays we sought to elucidate physical association of putative 
interaction partners and MESA. We observed some overlap of MESA with the 5 tested 
proteins PFE1605w, PFI1780w, PF3D7_0424600, band 4.1 and spectrin. However, co-
labelling immunofluorescence assays are in principle not conclusive to show interaction of 
two proteins. For a better analysis of association of two proteins, colocalization analysis upon 
confocal microscopy would be appropriate. However, this is hardly possible as MESA figures 
as “surface” in fluorescence microscopy due to its localization at the erythrocyte membrane 
and a colocalization analysis of those is not possible. High resolution immunoelectron 
microscopy or biochemical interaction studies would help validating interaction partners. 
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A MESA KO cell line was successfully generated in order to study MESA function. MESA 
function had been investigated before but without assigning a specific function to the protein 
(Petersen et al., 1989, Magowan et al., 1995, Cooke et al., 2002, Waller et al., 2003). 
However, the studies form Petersen, Magowan, Cooke and colleagues used a spontaneously 
mutated cell line not expressing MESA.  The exact extent of the deletion on chromosome 5, 
where the mesa gene is located, was not assessed. Thus it cannot be excluded that other genes 
besides the gene of interest were affected.  In this study we have generated a new 5’ MESA 
KO cell line by targeted single cross-over recombination disrupting mesa gene expression by 
insertion of a resistance marker. 
We found no growth defect of MESA deficient cells according to findings from Magowan 
and colleagues (Magowan et al., 1995). By semi-static binding assay against CD36 and 
scanning electron microscopy we also found MESA is not required for the formation of knobs 
and cytoadherence as previously published (Petersen et al., 1989, Magowan et al., 1995, 
Cooke et al., 2002).  
We found no difference in deformability of MESA KO and 3D7. We hypothesized that 
MESA would have an influence on the physical properties of the iRBC because of its 
localization at the host cell cytoskeleton. Similar observations were done with KAHRP and 
RESA. KAHRP is a constituent of knobs, KAHRP KO parasites have no knobs and are more 
deformable as wildtype parasites (Glenister et al., 2002). RESA localizes to the cytoskeleton 
and was suggested to have a role in temperature-dependent membrane stability as under heat 
stress RESA KO were found to be more deformable than wildtype iRBCs (Mills et al., 2007).  
The microsphiltration method accurately reflects the physiological function of the spleen 
(Deplaine et al., 2011). There are other methods to assess deformability properties of an entire 
iRBC (e.g. microfluidics,  Myrand-Lapierre et al., 2015) or of the iRBC membrane 
specifically (e.g micropipette aspiration,  Glenister et al., 2002). Though, it is conceivable that 
the microsphiltration method used in this study is not able to detect the dynamic range of the 
deformability changes (if any) upon MESA deletion. 
In conclusion we identified putative MESA interaction partners at the host cytoskeleton 
localization and exclude a function of MESA in knob formation, CD36 binding and 
deformability alteration.  
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Figure legends 
Figure 1: Endogenous MESA-GFP expression. A: Western blot analysis with α-GFP 
antibody shows expression of MESA-GFP in the MESAP-GFP and not in 3D7 parasite 
lysates. α-GAPDH antibody was used as loading control B: Immunofluorescence microscopy 
reveals MESA-GFP localization at the iRBC membrane of MESA-GFP parasites probed with 
α-MESA and α-GFP antibodies. Scale bar 2µm. C: Time course western blot with α-GFP 
antibody of MESA-GFP parasite lysates shows expression of MESA-GFP in trophozoite and 
schizont stages. α-GAPDH antibody staining was used as loading control. hpi: hours post 
infection D: Time course immunofluorescence assays of 3D7 parasites with α-MESA 
antibodies confirms MESA expression and localization at the iRBC membrane in trophozoite 
and schizont stages. Scale bar 2µm. hpi: hours post infection E: Cytoskeleton imaging with α-
MESA and α-GlycophorinA/B antibodies shows MESA localization at the inner surface of 
the iRBC membrane. Scale bar 10µm. 
 
Figure 2: Localization of MESA-GFP potential protein interaction partners. A: 
Immunofluorescence assay co-labelling MESA-GFP, 3D7, and PF3D7_0424600-GFP iRBCs 
with α-MESA, α-GFP, α-PFE1605w, and α-PFI1780w antibodies. Scale bar 2µm. B: 
Immunofluorescence assay co-labelling MESA-GFP iRBC with α-GFP, α-band 4.1. and α-
spectrin. Scale bar 2µm. 
 
Figure 3: Phenotypical analysis of MESA KO infected red blood cells. A: Southern blot 
confirming the replacement of MESA with a hDHFR cassette. Digested gDNA was run on an 
agarose gel and then probed with the 5’ integration stretch. The expected band sizes are for 
3D7 2529 bp, for MESA KO 3409bp and 3030 bp and for the plasmid 3910 bp. B: Growth 
assay of 3D7 and MESA KO iRBCs over 5 days, parasitemia was determined by FACS 
analysis, and an exponential curve was fitted. Shown are mean of triplicates with standard 
deviation. C: CD36 semi-static binding assay of 3D7 and MESA KO iRBCs. Shown are mean 
of triplicates with standard deviation. D: Time course deformability assay of 3D7 and MESA 
KO iRBCs of tightly synchronized cells. Shown are mean of biological duplicates with 
standard deviation. E: Scanning electron microscopy of uninfected red blood cell (RBC), 
wildtype 3D7 iRBC and MESA KO iRBC. Scale bar 2µm. 
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Figure 4: Localization of MAHRP2 and RESA in MESA KO infected red blood cells. A: 
Immunofluorescence assay labelling 3D7 and MESA KO iRBCs with α-MAHRP2 antibody. 
Scale bar 2µm. B: Immunofluorescence microscopy labelling of 3D7 and MESA KO ring and 
trophozoite iRBCs with α-MESA and α-RESA antibody. Scale bar 2µm. 
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Figure 2 
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Figure 3 
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Figure 4 
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Introduction 
 
The Sporozoite Threonine and Asparagine-Rich Protein (STARP, PF3D7_0702300) was first 
described on the surface of Plasmodium falciparum sporozoites (Fidock et al., 1994a). 
Additionally, STARP was reported to be expressed in liver stages and early ring stages 
(Fidock et al., 1994a, Bozdech et al., 2003). STARP is also present in other Plasmodium 
species and has a highly conserved structure. The 78kDa protein contains 45-amino acid 
repeats which are highly enriched for asparagine and threonine being eponymous for it. These 
repeats are followed by multiple interspersed motifs of decapeptide repeats (Fidock et al., 
1994b) and a C-terminal non-repetitive sequence. Several phosphorylation sites were 
predicted in the STARP protein (Treeck et al., 2011). 
STARP is regarded as a potential pre-erythrocytic stage vaccine candidate due to its 
immunogenicity in various animal models and humans (Fidock et al., 1997, Lalvani et al., 
1996, Perlaza et al., 1998). Further, STARP antibodies from malaria-exposed individuals 
were found to be efficient in blocking sporozoites from entering hepatocytes in vitro (Fidock 
et al., 1997, López et al., 2003).  
We have identified STARP in intraerythrocytic stages by co-immunoprecipitation studies of 
tethers with antibodies directed against the exported protein MAHRP2. STARP contains a 
PEXEL motif and is thus putatively exported to the host cell. Episomal expression of STARP-
GFP indeed showed that the protein is exported and localizes partially to Maurer’s clefts. 
However, no specific localization to tethers was observed (unpublished).  
In this study we aimed at the characterization of STARP in the intraerythrocytic life cycle by 
investigating the endogenous protein. To this end a GFP-tag was introduced at the C-terminal 
end of STARP by CRISPR/Cas9-selection-linked integration (SLI) (Ghorbal et al., 2014, 
Birnbaum et al., 2017) genome editing technology. In addition, a STARP knock out cell line 
was generated by single cross-over recombination and functional protein studies were 
performed.  
 
Methods 
Cell culture and transfections 
P. falciparum 3D7 was cultured and transfected as described (Moll et al., 2013). Transfected 
parasites were positively selected with 10nM WR99210 (Jacobs Pharmaceuticals, Cologne, 
Germany). 
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Plasmid constructs  
The STARP-GFP cell line was generated using a combined CRISPR/Cas9-SLI technology 
approach. Homology regions between 300-1000bp were designed, the gRNA was chosen with 
the CHOPCHOP software (Labun et al., 2016, Montague et al., 2014), and the gRNA 
recognition sequence in the 5’ homology region was mutated to avoid (re)cleavage of 
successfully tagged endogenous protein. The homology regions and gRNA were PCR 
amplified using primers listed in Supplementary Table 1 and cloned into 
pCRISPR_GFP2ABSD using the In-Fusion® HD Cloning Kit (Clontech® Laboratories, 
Inc.). pCRISPR_GFP2ABSD contains the Cas9, the gRNA, and the integration cassette 
flanked by the 5’ and 3’ homology regions. The integration cassette consists of the GFP-tag 
and a bsd selection marker separated by a 2A skip peptide (Szymczak et al., 2004) and a 
terminator. The selectable marker lacks a promotor and can only be expressed after successful 
integration into the target locus. The skip peptide triggers a ribosomal skip mechanism and 
thus impairs normal peptide bond formation preventing the attachment of the selection marker 
to the target protein (Donnelly et al., 2001).  
The STARP KO cell line was generated by single cross-over recombination. Thereby a 
hDHFR selection marker disrupting the starp gene was introduced into the parasite genome 
via a homologous targeting sequence. To this end a stretch of the starp gene was PCR 
amplified using primers listed below and cloned with EcoRI and BamHI into the pH-KO 
plasmid. After transfection, on/off drug selection cycling was performed to select for stably 
integrated constructs and remove residual episomal constructs. 
 
Southern blot analysis 
Southern blot analysis was performed to show starp disruption in the pH-KO-STARP plasmid 
transfected parasites. Genomic DNA was isolated by phenol/chloroform extraction of saponin 
lysed parasites. gDNA was digested with AvaI & HincII restriction enzymes, separated on a 
0.8% agarose gel and transferred onto a Amersham Hybond-N+ membrane (GEHealthcare). 
Blots were probed with 
32
P-dATP-labelled probe fragments. The probe was the starp 
homologous targeting sequence used for pH-KO plasmid contruction. 
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Western blot analysis 
Parasite saponin lysates were obtained from 10ml culture (5% hematocrit, 5-10% parasitemia 
(Pachlatko et al., 2010) and run on 4-12% Bis/Tris precast gels (NuPAGE®, Life 
Technologies) according to the manufacturers’ protocol (2017). Protein transfer was 
performed with the iBlot 2.0 onto a 0.2µm pore size nitrocellulose membrane (Life 
Technologies). Subsequently, the membrane was blocked with 10% skimmed milk/TNT 
(0.1% Tween in 100mM Tris, 150mM NaCl) and probed with the first antibody diluted in 3% 
skimmed milk/TNT at room temperature for 2h-O/N. After 6 washes for 5min with TNT the 
secondary antibody conjugated to HRP was incubated in the respective dilution in 3% 
skimmed milk/TNT for 2h at room temperature. After another 6 washes for 5min with TNT 
the signal was detected by Super Signal West Pico Chemiluminescent Substrate (Thermo 
Scientific) or LumiGlo Reserve Chemiluminescent Substrate (Seracare) according to the 
manufacturers protocol. 
The antibodies used were: mouse α-GFP 1:250 (Roche), mouse α-GAPDH 1:20’000 
(Daubenberger et al., 2003), goat α-mouse-HRP 1:20’000 (Pierce).  
 
Fluorescence microscopy 
Thin blood smears of infected parasite cultures were fixed in ice-cold 60% methanol/40% 
acetone for 2min. After air-drying of the smear, a small circle was drawn with a hydrophobic 
pen and the respective area was blocked with 3% BSA/PBS for 1h at room temperature in a 
humidified chamber. Then, the cells were incubated with mouse α-MAHRP1 (Spycher et al., 
2003) (1:100), rabbit α-MAHRP2 (Pachlatko et al., 2010) (1:100), mouse α-ATS (1:50), 
mouse α-GFP (Roche, 1:100) in 3% BSA/PBS for minimum 2h at room temperature in a 
humidified chamber. After 3 washes with 3% BSA/PBS for 7min the secondary antibodies 
(goat α-mouse Alexa488, goat α-rabbit Alexa488, goat α-rabbit Alexa568, goat α-rat 
Alexa568; all Invitrogen, 1:200) were applied in the appropriate dilution in 3% BSA/PBS for 
minimum 1h at room temperature in a humidified chamber. After another 3 wash steps with 
3% BSA/PBS for 7min each, a coverslip was mounted with 2µl VECTASHIELD® with DAPI 
(Vector Laboratories Inc.). For imaging a 63x oil-immersion lens (1.4 numerical aperture) on 
a Leica 5000 B microscope was used. The images were obtained and analyzed with Leica 
ApplicationSuite 4.4. and Fiji (Schindelin et al., 2012). 
 
Characterization of the Plasmodium falciparum Sporozoite Threonine and Asparagine-Rich 
Protein (STARP) in the intraerythrocytic cycle 
 
99 
Growth assay 
Asynchronous parasite infected cell cultures were set up at 0.2% parasitemia. Parasitemia was 
determined by flow cytometry and followed over 5 days. Parasites were stained with SYBR® 
Green I nucleic acid gel stain (Sigma-Aldrich) 1:5000 for 20min at 37°C in the dark, washed 
3x with culture medium and 100’000 cells were assessed with a BD FACSCalibur. The 
experiment was performed in biological triplicates, standard deviations of parasitemias were 
calculated and exponential curves fitted to the data points. 
 
Binding assay 
Semi-static binding assays were performed as published before (Oberli et al., 2016). Human 
CD36 recombinant protein (Sino Biological, China) was spotted on wells of eight-chamber 
cell culture glass slides (Falcon, Big Flats, NY, USA) in 50µg/ml concentrations and 
incubated overnight at 4°C to allow proteins to absorb to the surface. The wells were blocked 
with 1% BSA/PBS for 1h at 37°C. Parasite cultures were washed twice with RPMI-HEPES 
and spotted onto immobilized CD36 and cultured for 2h under continuous and simultaneous 
shaking (140 rpm, proBlot 25 Rocker; Labnet International Inc., NY, USA) (105 rpm, Lab-
Therm LT-W, Kühner, Switzerland) at 37°C. Non-bound erythrocytes were removed by six 
gentle washes with RPMI-HEPES with simultaneous shaking for 2min. Bound iRBCs were 
fixed with 2% glutaraldehyde in RPMI-HEPES overnight, stained with 10% Giemsa for 1h 
and microscopically counted. Results are shown as mean number of parasites bound per 
square millimetre and normalized to 1% parasitaemia. The experiment was performed in 
triplicates. 
 
Results and Discussion 
STARP is expressed in the intraerythrocytic lifecycle and exported to the host cytosol  
In order to analyze STARP expression, a GFP-tag at the STARP C-terminus was introduced 
with a combined CRISPR/Cas9-SLI approach. Correct integration of the tag-cassette into the 
genome was assessed by PCR (Figure 1A). Then, Western blot analysis was performed to 
check protein expression (Figure 1B). STARP-GFP was detected at a much smaller size 
(approx. 45kDa) as the calculated molecular weight of 95kDa. We excluded protein 
degradation during sample preparation by handling all samples in presence of protease 
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inhibitor cocktail and at 4°C. Therefore, we suggest that the protein is processed by the 
parasite.  
By fluorescence microscopy STARP-GFP was found to be exported to the iRBC cytosol and 
localizing in a dotted manner (Figure 1C). This confirms previous findings with episomally 
expressed STARP-GFP and indicates that the PEXEL motif is functional (unpublished).  
Time course Western blot analysis showed STARP-GFP expression in the first half of the 
intraerythrocytic life cycle (Figure 1D). The protein expression therefore reflects nicely the 
transcriptome data from Bozdech et al.  (2003).  
 
STARP partially localizes to Maurer’s clefts 
By co-labeling immunofluorescence assays the localization of STARP-GFP was investigated. 
As very long exposure times were needed to detect the STARP-GFP signal, it might be 
speculated that either STARP-GFP is weakly expressed or the GFP-tag is not accessible to the 
antibody (due to cleavage or protein folding). For the latter case a change of tag could help to 
overcome the problem of weak signal. However, we found partial co-labeling of STARP-GFP 
with MAHRP1 indicating a transient or partial localization to Maurer’s clefts (Figure 2A). No 
co-labeling of STARP-GFP and MAHRP2 was observed (Figure 2B), and therefore it can be 
excluded that STARP-GFP is a tether component or tether-associated protein. This is in 
accordance with previous observations with episomally expressed STARP-GFP 
(unpublished). 
 
STARP functional analysis  
To investigate the function of STARP, we generated a 5’ single cross-over STARP knock out 
parasite line. Successful knock out (integration of a hDHFR cassette to disrupt the gene) was 
confirmed by Southern blot (Figure 3A). There is some residual plasmid in the knock out 
parasite cell line, which is usually lost over the course of several generations. The knock out 
was viable indicating that STARP is dispensable for the parasite in culture. We assessed 
growth of the STARP knock out cell line and no significant growth difference was observed 
compared to wildtype 3D7 parasites (Figure 3B). 
A CD36 semi-static binding assay was performed to investigate whether STARP is involved 
in PfEMP1 transport or PfEMP1 anchoring to the iRBC surface. There was no significant 
difference in binding to CD36 between the STARP knock out strain and wildtype 3D7 iRBCs 
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(Figure 3C). The parasites were not preselected to express CD36 binding PfEMP1 variants. 
However, with previous binding assays with CD36 preselected parasites we have observed 
binding in the same range (Oberli et al., 2016). Thus we assume that both parasite lines 
express a CD36 binding PfEMP1 variant. By immunofluorescence assay we checked PfEMP1 
localization in wildtype 3D7 and STARP knock out iRBC (Figure 3D). There is a stronger 
ATS signal observed within the parasite of STARP knock out iRBCs. Also the ATS signal at 
Maurer’s clefts is more pronounced in wildtype 3D7 iRBCs compared to STARP KO iRBCs. 
With great care, this may indicate a PfEMP1 transport defect in STARP deficient iRBCs.  
Further we analyzed the localization of MAHRP1 (Figure 4A) and MAHRP2 (Figure 4B) in 
STARP knock out cells by immunofluorescence microscopy. We didn’t find a difference 
between knock out and wildtype parasites. This indicates that STARP absence is not affecting 
the localization of MAHRP1 and MAHRP2, and STARP probably has no role in their 
trafficking. 
 
Summary and Conclusion 
We have endogenously GFP-tagged STARP and found that STARP is (weakly) expressed and 
exported in the intraerythrocytic cycle, and partially localizing to Maurer’s clefts. The 
Western blot results suggested that the protein is processed as we detected it at a significantly 
smaller size than anticipated by molecular weight calculations. By introducing the 
endogenous tag fused to a resistance cassette we apply a certain pressure on the parasite to 
express the protein in order to survive and are maybe looking at an artefact expression that is 
not reflecting the natural parasite situation. However, what holds against this argument is the 
presence of STARP transcripts in the intraerythrocytic life cycle (Bozdech et al., 2003) and 
the identification of STARP as a phosphoprotein in schizonts (Treeck et al., 2011). Still, we 
were not able to define the function of STARP in the P. falciparum intraerythrocytic life 
cycle. We assessed a putative function in PfEMP1 transport by performing a CD36 binding 
assay and ATS immunofluorescence assays with STARP knock out parasites. Nor in this 
neither in a localization study with MAHRP1 and MAHRP2 we found a distinct phenotype 
for the STARP knock out parasites.   
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Figure legends 
Figure 1: Endogenous STARP-GFP expression. A: The GFP2ABSD cassette was 
successfully integrated into the genome of STARP-GFP as shown by PCR. Primers were 
chosen outside the homology regions. The expected band sizes in 3D7 are 1530bp and for 
STARP-GFP cell line 3364bp B: Western blot analysis with α-GFP antibody shows 
expression of STARP-GFP in the STARP-GFP and not in 3D7 parasite lysates. α-GAPDH 
antibody as loading control C: Immunofluorescence microscopy reveals punctuate STARP-
GFP localization in the iRBC cytosol of STARP-GFP parasites probed with α-GFP antibody. 
Scale bar 2µm. D: Time course Western blot with α-GFP antibody of STARP-GFP parasite 
lysates shows expression of STARP-GFP in ring stages. α-GAPDH was used as loading 
control. 
 
Figure 2: Localization of endogenous STARP-GFP. A: Immunofluorescence microscopy 
co-labeling STARP-GFP with α-GFP and α-MAHRP1 antibodies. B: Immunofluorescence 
microscopy co-labeling STARP-GFP with α-GFP and α-MAHRP2 antibody. Scale bar 2µm. 
 
Figure 3: Phenotypical analysis of STARP KO parasites. A: Southern blot confirming the 
replacement of STARP with the hDHFR cassette. Digested gDNA was run on an agarose gel 
and then probed with the 3’ integration stretch. The expected band sizes are for 3D7 1651bp, 
for STARP KO 3620bp and 2211bp and for the plasmid (P) 4180bp. B: Growth assay of 3D7 
and STARP KO parasites over 5 days, parasitemia was determined by FACS analysis, 
exponential curve was fitted. Shown are mean of triplicates with standard deviation. C: CD36 
semi-static binding assay of 3D7 and STARP KO. Shown are mean of triplicates with 
standard deviation. D: Immunofluorescence microscopy labeling of 3D7 and STARP KO 
parasites with α-ATS antibody. Scale bar 2µm. 
 
Figure 4: Localization of MAHRP1 and MAHRP2 in STARP KO parasites. A: 
Immunofluorescence microscopy labeling of 3D7 and STARP KO parasites with α-MAHRP1 
antibody. B: Immunofluorescence microscopy labelling of 3D7 and STARP KO parasites 
with α-MAHRP2 antibody. Scale bar 2µm. 
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Figure 3 
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Chapter 5 
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Introduction 
Malaria is a devastating disease affecting millions of people. In order to maintain the positive 
trend of decreasing disease burden during the last 20 years and to strive for elimination of 
malaria, continuous effort is needed. Particularly, a good development pipeline for new, 
effective drugs is essential to counter arising resistance against existing treatment. A 
promising new class of antimalarials are spiroindolones which have been shown to act rapidly 
and effectively against Plasmodium falciparum and P. vivax (Rottmann et al., 2010, White et 
al., 2014). Spiroindolones are active against the pathology-relevant asexual intraerythrocytic 
stages (Lakshminarayana et al., 2015) as well as against the transmission-relevant sexual 
stages (van Pelt-Koops et al., 2012). Spiroindolones target the cation pump ATPase PfATP4 
localized in the parasite plasma membrane thereby disrupting the ion homeostasis inside the 
parasite (Spillman et al., 2013). The altered ion homeostasis not only has metabolic 
consequences on the parasite but also leads to altered biomechanical properties of the infected 
red blood cell (iRBC) (Zhang et al., 2016). The (uninfected) erythrocyte is a highly 
deformable cell as it needs to pass through the microvasculature. Erythrocytes are regularly 
passing the spleen where their deformability is assessed in the red pulp and abnormal e.g. P. 
falciparum iRBCs are removed from circulation. P. falciparum iRBC deformability decreases 
with progressing life cycle stages of the asexual parasite (Cranston et al., 1984). While P. 
falciparum trophozoite and schizont iRBCs avoid passage through the spleen by 
cytoadherence, P. falciparum ring iRBCs are transiting the spleen. Drugs that enhance the 
rigidification of iRBCs, especially in ring stages can enhance the filtering function of the 
spleen to remove iRBCs. The clinical spiroindolone compound cipargamin (KAE609) was 
reported to increase sphericity and reduce deformability of P. falciparum and P. vivax ring-
infected RBC (Zhang et al., 2016). 
Here we investigated changes in deformability of P. falciparum iRBC upon exposure to the 
spiroindolone KAF246, an analog of KAE609 (Yeung et al., 2010). For this we performed 
microsphiltration experiments, to assess P. falciparum iRBC deformability by mimicking the 
human spleen in vitro (Deplaine et al., 2011), and we further confirmed the in vitro findings 
with in vivo experiments using a P. berghei mouse model visualizing splenic clearance. By 
monitoring the pharmacodynamic effects of KAF246 on circulating Plasmodium iRBC we 
gain additional insight into the mechanism of the observed rapid parasite clearance upon 
spiroindolone treatment. 
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Methods 
Plasmodium falciparum culture and reagents 
P. falciparum 3D7 was cultured according to standard procedures (Moll et al., 2013). Parasite 
asexual stages were synchronized by MACS column (Miltenyi Biotec) (Ribaut et al., 2008) to 
a 4h time window. Gametocyte experiments were performed with the 3D7/pHcamGDV1-
GFPDD cell line as described (Filarsky et al., 2018). Briefly, this cell line over-expresses the 
master regulator gene GDV1 in an inducible manner. Addition of 1.25mM Shield-1 (Viva 
Biotech (Shanghai) Ltd.) to a synchronously growing ring stage parasite culture for 48h 
stabilizes GDV1 and thus triggers gametocytogenesis. After reinvasion, the cultures were kept 
5 days on medium containing 50mM N-Acetylglucosamine (Sigma) to kill remaining asexual 
blood stages and to obtain a pure gametocyte culture. Afterwards, cultures were maintained 
with regular medium until harvest. 
 
Microsphiltration 
Tightly synchronized parasite cultures were treated with 20nM KAF246 in ring stages (14-18 
hpi), trophozoite stages (30-34 hpi), and schizont stages (38-42 hpi). Microsphiltration 
experiments were performed after 1h, 2h, 4h and 8h of drug addition as described in Lavazec 
et al. (2013). Parasitemia of the flow-through sample was determined by flow cytometry and 
compared to the similarly measured parasitemia of the input samples. Parasites were stained 
with SYBR® Green I nucleic acid gel stain (Sigma-Aldrich) 1:5000 for 20 minutes at 37°C in 
the dark, washed 3x with culture medium and 100’000 cells were assessed with a BD 
FACSCalibur. All experiments were performed in technical triplicates. Retention rates (in %) 
were calculated as 1−(parasitemia flow through sample/parasitemia input sample)×100. 
Microsphiltration of uninfected erythrocytes was performed as described above. Of the 
uninfected erythrocytes, a defined fraction of cells was labelled with the green fluorescent 
membrane stain PKH67 (Sigma-Aldrich) according to manufacturer’s protocol. This enabled 
their monitoring by flow cytometry during the experiment.  
 
Mice/Plasmodium berghei 
Mice were infected with 2x10
7
 P. berghei PbmCherryhsp70 + Luceef1α parasites (Prado et al., 
2015) and treated after 24h with 1x50mg/kg or 1x10mg/kg KAF246 po respectively. 
Parasitaemia was monitored with the in vivo imaging system (IVIS II, PerkinElmer) to 
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monitor bioluminescence signal (100 mg/kg of D-luciferin was intravenously injected 3 min 
before imaging) at 1h, 2h, 4h, 6h, 8h, 24h, 48h, 72h, 144h, 240h post treatment. In addition 
blood smears were obtained from selected mice and viewed under a microscope after Giemsa 
staining.  Animal experiments were carried out at the Swiss Tropical and Public Health 
Institute (Basel, Switzerland), adhering to local and national regulations of laboratory animal 
welfare in Switzerland (awarded permission no. 1731 and 2566).  
 
Results 
To evaluate the stage-specific effect of KAF246 on the deformability of P. falciparum iRBCs 
we performed microsphiltration experiments with highly synchronous asexual parasites. 
Parasites were treated with 20nM KAF246, which represents approximately 100 fold the IC50 
(Lakshminarayana et al., 2015) for 1h, 2h, 4h, and 8h and increased retention rates upon 
KAF246 treatment were found for all incubation times and for all stages. The control ring 
stages had retention rates of 18.10%±5.58, 21.29%±6.31, 17.34%±5.92, and 23.08%±5.58 
whereas KAF246 treated ring stages had 17.93%±6.70, 22.54%±11.07, 38.67%±9.02, and 
44.03%±5.84 retention after 1h, 2h, 4h, and 8h treatment, respectively (Figure 1A). For 
control trophozoite stages retention rates of 51.80%±11.15, 72.14%±10.59, 68.98%±8.64, and 
57.25%±24.72 and for KAF246 treated trophozoite stages retention rates of 69.00%±13.96, 
80.04%±12.19, 87.64%±8.88, and 93.94%±4.10 were measured after 1h, 2h, 4h, and 8h, 
respectively (Figure 1B). Finally, the retention rates observed in control schizont stages were 
54.21%±20.57, 61.97%±10.95, 55.41%±7.09, and 60.66%±15.08 versus 73.51%±10.72, 
83.03%±7.39, 89.42%±4.71, and 95.64%±6.16 retention in KAF246 treated schizont stages 
after 1h, 2h, 4h, and 8h, respectively (Figure 1C). In summary, short treatment (1 and 2 hours) 
had no effect on the retention rate of ring stage parasites but the retention rate doubled after 4 
hours KAF246 exposure. In trophozoite and schizont stages increased retention rates were 
observed already after 1h of KAF246 exposure. The stiffening effect on trophozoites 
increased steadily to a maximum after 8h drug exposure. In schizonts the stiffening effect 
increased more pronounced after 1h than in trophozoites but the maximum increase was 
slightly lower than in trophozoites.  
In order to test the effect of KAF246 on the deformability of transmissible parasite stages we 
performed microsphiltration experiments with P. falciparum gametocytes treated with 
KAF246. No deformability differences between treated and untreated stage III gametocytes 
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were observed (data not shown), but reduced deformability in KAF246-treated stage V 
gametocytes was detected. For control stage V gametocytes retention rates of 39.82%±14.12, 
36.53%±14.00, and 55.46%±3.48 and for KAF246 treated stage V gametocytes retention rates 
of 71.71%±5.71, 68.42%±9.10, and 70.34%±2.43 were measured after 1h, 2h, and 4h, 
respectively (Figure 1D). 
Next, we addressed the question whether the observed in vitro rigidity changes upon KAF246 
treatment are reflected in enhanced accumulation of iRBCs in the spleen in in vivo 
experiments. To this end, P. berghei PbmCherryhsp70 + Luceef1α infected mice were treated 
with 50mg/kg or 10mg/kg KAF246 and parasitemia was monitored by bioluminescence (after 
luciferin injection) after 1h, 2h, 4h, 6h, 8h, 24h, 48h, 3d, 6d, and 10d (Figure 2A). After 2h 
treatment with KAF246 we observed an increased parasite load in the spleens of treated mice. 
A dose dependent accumulation was observed when comparing the parasite accumulation in 
the 50mg/kg and 10mg/kg group after 2h. After 4h and 8h of drug exposure the parasite load 
in the spleen further increased but was comparable between both dose groups. After 24h only 
a few parasites were found in the spleen and after 48h KAF246 exposure all treated mice were 
devoid of detectable parasites. The treated mice were monitored for 10 days after drug 
administration and recrudescence of parasites was observed after 6 days and 10 days in the 
10mg/kg and 50mg/kg treatment group, respectively. Next, we evaluated the stage-specific 
effect of KAF246 on P. berghei by analyzing Giemsa-stained blood smears from the above 
mouse experiment (Figure 2B and 2C). The blood smears represented the circulating parasite 
population in the infected mice. In untreated control mice (Figure 2B) we found a parasite 
population composition of 42% rings/50% trophozoites/8% schizonts after 1h, 43% 
rings/47% trophozoites/9% schizonts after 2h, 22% rings/63% trophozoites/15% schizonts 
after 4h, and 26% rings/61% trophozoites/13% schizonts after 8h. In 50mg/kg KAF246 
treated mice 48% rings/47% trophozoites /6% schizonts after 1h, 57% rings/43% 
trophozoites/0% schizonts after 2h, 75% rings/24% trophozoites/1% schizonts after 4h, and 
68% rings/32% trophozoites/0% schizonts after 8h drug exposure were observed. In 
summary, KAF246-treated mice harbored fewer trophozoites and schizonts when compared 
to untreated control mice suggesting a rapid clearance of older stages. 
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Discussion 
In order to address the hypothesis that the rapid parasite clearance upon KAF246 treatment is 
due to increased cell rigidity we performed microsphiltration experiments. Our data show that 
the spiroindolone KAF246 causes a rapid rigidity increase of both asexual and sexual stage P. 
falciparum iRBCs (Figure 1). The stage-specific retention rates we report for untreated ring 
and trophozoite control parasites are coherent with previously published observations (Sanyal 
et al., 2012). It is expected that retention rates of the control parasites increase during the 
experiment according to their progression in the lifecycle (Cranston et al., 1984). Instead, 
retention rates are not rising over time in all conditions. This may be explained by increased 
stress of the parasite cultures excerted by the experimental manipulations. Further, we found 
lower retention rates than expected in the control schizont fraction which might be explained 
by the early presence of ring stages already observed in Giemsa smears of this fraction 
perhaps due to the late addition of drug during the life cycle.  
We observed that schizonts responded fastest to KAF246 treatment (after 1h) and with 
highest increase of retention rates. Ring and trophozoite stages reacted with a lower increase 
and ring stages responded even later (after 4h drug exposure) to KAF246 treatment. 
Gametocyte development has been reported to be impaired by spiroindolone KAE609 
treatment (van Pelt-Koops et al., 2012), and all gametocyte stages have been shown to be 
susceptible to KAF246 (Plouffe et al., 2016). 
Based on the in vitro results with P. falciparum, we propose that KAF246-induced rigidity 
changes of treated iRBCs would lead to an accumulation of iRBCs in the spleen followed by 
an effective removal from the circulation. This is supported by the observation of a rapid 
accumulation of P. bergei iRBCs in the spleen of mice treated with KAF246 (Figure 2A). We 
acknowledge that P. falciparum and P. berghei biology is quite distinct and that the 
physiology of the human and mouse spleen is slightly different. However, it was reported that 
metabolic stability of the spiroindolone KAE609 is comparable in humans and rodents 
(Rottmann et al., 2010). One difference is that P. berghei does not cytoadhere, hence all 
parasite stages pass the spleen regularly. This is reflected in the enumeration of different life 
cycle stages in the blood of the mice. Therefore it was possible to confirm in vitro 
pharmacodynamic stage specific differences in vivo where we observed a more rapid 
depletion of late stage parasites (Figure 2B and C). The in vivo pharmacodynamics (rapid 
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clearance in the spleen) correlates well with the observations made with microsphiltration 
experiments in P. falciparum. 
Cell deformability is influenced by several factors, e.g internal viscosity, membrane and 
cytoskeleton dynamics, and cell geometry. Therefore it is not surprising that drugs with 
different mode of actions affect it, e.g. artesunate (Huang et al., 2013) and chloroquine 
(Huang et al., 2014).  Nevertheless, spiroindolones seem to be unique in the way they kill the 
parasite with the combined effect of inhibiting essential biochemical processes and inducing 
altered deformability of iRBC with fatal consequences for the parasite leading to rapid 
clearance from the blood stream and relief for the patients. Notably, this is the first study to 
investigate the effect of the spiroindolone KAF246 on gametocyte deformability.  
In conclusion, this study supports an explanation that the fast parasite clearance in vivo upon 
treatment with the new spiroindolone compound class might be due to increased rigidity of 
iRBCs leading to parasite accumulation in the spleen. Our results of stage V gametocyte 
rigidification upon KAF246 treatment indicate a possible additional effect (besides killing 
stage V gametocytes) on preventing transmission by fast removal of circulating mature 
gametocytes by the spleen. 
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Figure legends 
Figure 1: KAF246 exposure leads to an increase of iRBC deformability in all 
intraerythrocytic life stages. Shown are microsphiltration retention rates of tightly 
synchronized P. falciparum ring (A), trophozoite (B), and schizont (C) and stage V 
gametocyte (D) cultures. Open squares represent untreated control P. falciparum iRBCs, 
filled squares 20nM KAF246 treated P. falciparum iRBC after 1h, 2h, 4h, and 8h drug 
exposure. All experiments were performed in biological triplicates, error bars represent 
standard deviation. 
 
Figure 2: KAF246 treatment of mice leads to parasites accumulation in the spleen. P. 
bergei PbmCherryhsp70 + Luceef1α infected mice were treated with 50mg/kg or 10mg/kg 
KAF246 oral dose and parasitemia was monitored after 1h, 2h, 4h, 8h, 24h, and 48h drug 
exposure by IVIS bioluminescence (A). Bioluminescence signals were normalized between 
timepoints. Giemsa smears were prepared concomitant to bioluminescence measurements. 
They were microscopically analyzed and parasite stages were determined. Shown are ratios of 
ring (white), trophozoite (shaded), and schizont (black) parasites in control (B) and 50mg/kg 
KAF246 treated (C) mice. Minimum 100 parasites per smear were stage-assigned. 
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Figure 1 
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Figure 2 
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Chapter 6 
General Discussion 
 
The malaria parasite P. falciparum triggers devastating pathology during its intraerythrocytic 
life cycle stage. In order to thrive, the parasite extensively remodels the terminally 
differentiated red blood cell to make it a favorable environment for massive replication. The 
refurbishment is mediated by a large number of parasite proteins that are exported to the host 
cell. The main pathways and processes installed by the parasite are 1) a protein trafficking 
network enabling the presentation of variant surface antigens that facilitate immune evasion 
and 2) the installation of nutrient uptake channels. In this study we set out to characterize 
three exported proteins initially identified in MAHRP1 and/or MAHRP2 co-
immunoprecipitation experiments aiming at a better understanding of Maurer’s clefts and 
Maurer’s clefts tether function. These are PF3D7_0702500, MESA (PF3D7_0500800) and 
STARP (PF3D7_0702300). Apart from localization and expression studies, we performed 
protein interaction studies and protein functional analyses. Instrumental for the study were 
transgenic parasites and knock out cell lines were generated using the CRISPR/Cas9 system 
(Ghorbal et al., 2014). For gene tagging, a new approach combining the CRISPR/Cas9 system 
with selection linked integration (Birnbaum et al., 2017) was applied. The availability of these 
recent gene editing technologies accelerates the establishment of transgenic parasite cell lines 
to study specific proteins of interest.  
All cellular processes are guided by proteins functioning in concert with other proteins. The 
understanding of protein-protein interactions is thus a substantial part of understanding 
biological processes. We were particularly interested in identifying protein networks of 
exported P. falciarum proteins around Maurer’s clefts that are putatively involved in the 
establishment of a protein trafficking system. LaCount and colleagues predicted many P. 
falciparum asexual stage protein-protein interactions by a high-throughput yeast two hybrid 
system approach (LaCount et al., 2005). Among the different protein interaction clusters they 
also looked more specifically at exported proteins. They found 15 interactions among 19 
exported proteins. One of these analyzed clusters involved MESA (PF3D7_0500800) 
interacting with SBP1 (PF3D7_0511300), PTP4 (PF3D7_0730900), PF3D7_0702100, and 
PF3D7_1401200. None of these predicted MESA interaction partners was confirmed in our 
MESA-GFP co-immunoprecipitation experiments (see chapter 4). The yeast two hybrid 
system used by LaCount and colleagues is an in vitro technique where protein domains are 
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expressed recombinantly, simultaneously and in the same cellular compartment. In contrast, 
co-immunoprecipitation experiments capture protein-protein interactions in the physiological 
environment. To confirm interaction between two proteins several different techniques should 
be applied, especially also biochemical interaction studies, e.g. fluorescence polarization 
binding assays, far Western blot, surface plasmon resonance, or NMR studies to validate 
direct physical interaction of two proteins. BioID is a relatively new method to identify 
proteins in close proximity of each other in vivo (Roux et al., 2013). A promiscuous biotin 
ligase fused to a protein of interest biotinylates proteins based on poximity and has been 
successfully applied in Plasmodium (Khosh-Naucke et al., 2017, Schnider et al., 2018). We 
have adapted this system in our experiments and successfully identified potential interaction 
partners for MESA and several PHIST family proteins.  
The parasite-derived exported proteins do not only interact with other parasite-derived 
proteins but also with host red blood cell proteins. An example is the interaction of MESA 
with the erythrocyte skeletal protein 4.1 which is essential for parasite survival (Magowan et 
al., 1995). The investigation of protein-protein interactions from the host perspective is very 
challenging in the intraerythrocytic life cycle as the host cell cannot be easily genetically 
manipulated because it lacks a cell nucleus. However, the feasibility to use red blood cells 
derived from genetically manipulated hematopoietic stem cells to study host cell factors 
important for P. falciparum invasion was shown by Egan et al. (2015). 
Over the last years, our laboratory has performed several co-immunoprecipitation protein 
interaction studies with various exported proteins. To get an impression of the 
interconnectedness of several exported proteins, a network with the co-immunoprecipitation 
data of SEMP1 (Dietz et al., 2014), MAHRP2 (unpublished), PF3D7_0702500-HA (chapter 
3), and MESA-GFP (chapter 4) was assembled (Figure 1). These four proteins represent 
different structures in the iRBC cytosol: the iRBC cytoskeleton (MESA), electron-dense 
structures (PF3D7_0702500), Maurer’s clefts tethers (MAHRP2) and Maurer’s clefts 
(SEMP1).  
The central node connected to MESA, PF3D7_0702500, MAHRP2 and SEMP1 contains 
REX1, PIESP2, Hsp70x and GBP130 (light green protein group). REX1 is a Maurer’s clefts 
protein important for PfEMP1 delivery to the iRBC surface (Hawthorne et al., 2004, Dixon et 
al., 2011). PIESP2 also localizes to Maurer’s clefts and is important for the formation of 
Maurer’s clefts lamellar structure (Vincensini et al., 2005, Zhang et al., 2018). Their location 
in the center of the network underpins the central role of Maurer’s clefts as protein trafficking 
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hubs. Hsp70x is an exported chaperone (Kulzer et al., 2012) and its interaction with many 
“client proteins” is comprehensible given that it assists protein folding. Interestingly, the co-
chaperone Hsp40 (PFE55), which was previously found in complex with Hsp70x (Kulzer et 
al., 2010, Kulzer et al., 2012) was identified to interact with MESA and MAHRP2. GBP130 
is an exported protein of unknown function. It was previously proposed to bind host cell 
glycophorin (Kochan et al., 1986, Ravetch et al., 1985), but this result was later questioned by 
van Schravendijk and colleagues (1987). Further, GBP130 was identified by Maier and 
colleagues to modulate host cell rigidity (Maier et al., 2008), however its exact localization 
and function is unclear.  
Several proteins in the network belong to the PHIST protein family: PF3D7_0402000 
(PHISTa), PF3D7_1201000 (PHISTb), PF3D7_0424600 (PHISTb), PF3D7_0731300 
(PHISTb), PFE1605w (PHISTb), PF3D7_0801000 (PHISTc), and PFI1780w (PHISTc). This 
protein family has not been intensively studied but it seems that some PHIST proteins may 
function as “adaptor proteins” due to several occurring binding domains (reviewed in 
Warncke et al., 2016). Further studies on PHIST protein interactions will elucidate their role 
in host cell remodeling. 
An intriguing protagonist of the network is CLAG3.1, a Plasmodium surface anion channel 
(PSAC) protein (Nguitragool et al., 2011). Little is known to date about the parasite-induced 
host cell changes enabling nutrient uptake, a crucial process for parasite survival (further 
detailed below). 
In summary, this visualization of protein-protein interactions can be the basis for follow-up 
studies on exported proteins in consideration of the fact that many proteins are of unknown 
function. Elucidating the role of proteins located at intersection points may give new insights 
into processes established by the parasite.  
These non-human parasite-specific pathways represent targets for new antimalarial drug 
development.  Especially the unconventional protein trafficking pathways established in the 
host erythrocyte represent a unique opportunity to interfere with the mechanisms underlying 
the clinical symptoms of the disease. To this end, the functional characterization of exported 
parasite proteins is indispensable. However, the function of many exported proteins remains 
unclear. Actually, it even seems that many exported proteins are dispensable as a range of 
knock out cell lines shows no distinct phenotype.  
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Figure 1: Interaction network of exported P. falciparum proteins. Shown are protein interactions identified by 
co-immunoprecipitation. The datasets of SEMP1-3xHA (Dietz et al., 2014), MAHRP2 (unpublished), 
PF3D7_0702500-3xHA (chapter 3) and MESA-GFP (chapter 4) were compared and all proteins that interact 
with a minimum of two of the bait proteins are shown. Light green are the proteins interacting with all four bait 
proteins.  
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On one hand this could be explained by a high redundancy of exported proteins due to their 
position at the interface to the host, enabling the parasite to respond to the unstable 
environment, for example the adaptive host immune system. This is shown by the findings of 
a systematic functional genome screen in P.bergei (Bushell et al., 2017) as well as in a large-
scale gene knock out study of exported proteins (Maier et al., 2008) which reported that 
essentiality and phenotypical changes upon protein depletion were minor.  
On the other hand it needs to be considered that the majority of the functional characterization 
data is from in vitro culture systems.  Under cell culture conditions, the parasites have 
virtually unlimited supply of nutrients in very rich culture media and no host immune system 
is present. This may lead to an unintended miss of distinct phenotypes. An example is a study 
where the essentiality of the PSAC was only evident once the culture media composition was 
changed to contain lower concentrations of key nutrient components which notably were also 
closer to human plasma concentrations (Pillai et al., 2012). One can speculate that this is one 
of the reasons why so little is known about PSAC/NPPs. Recently, a model for PSAC 
assembly was proposed in which CLAG3, RhopH2 and RhopH3 form a complex and are 
trafficked to the rhoptries of the merozoite. Upon RBC invasion the complex is transferred to 
the iRBC parasitophorous vacuole. Then the proteins reach the iRBC cytosol via PTEX and 
finally reach the iRBC membrane via Maurer’s clefts (Ito et al., 2017, Sherling et al., 2017). 
The interruption of the PSAC assembly process would putatively lead to a starving out of the 
parasite and thus could be an attractive intervention strategy.  
Alteration of the biomechanical properties of P. falciparum iRBCs is another important factor 
for malaria pathogenesis: the hemodynamic properties of iRBCs are changed (Dasanna et al., 
2017), their retention in the spleen is modified and cytoadherence (resulting in blockage of 
small capillaries) is facilitated (Dondorp et al., 2000, Lavazec, 2017). It is not clear whether 
altered iRBC biomechanical properties are a necessity for parasite survival or an unavoidable 
side effect of protein export. Nevertheless, the molecular mechanisms behind the parasite-
induced changes in host cell deformability are more and more understood.  
Generally, cell deformability is influenced by the internal viscosity of the cytoplasm, 
membrane and cytoskeleton dynamics, and cell geometry. The presence of the parasite inside 
the cell influences all these factors, either by its sole presence or by remodeling the host cell, 
e.g. the establishment of knob structures on the iRBC surface. 
Alteration of host erythrocyte deformability starts during P. falciparum merozoite invasion 
(Sisquella et al., 2017, Koch et al., 2017): when the merozoite binds to the erythrocyte, the 
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viscoelastic properties of the host membrane change allowing the parasite to invade the cell. 
During the asexual stages, the iRBCs become increasingly rigid with progression of the 
parasite from young ring stages to late schizont stages (Cranston et al., 1984, Nash et al., 
1989). The underlying mechanisms are manifold and include parasite growth and host cell 
remodeling.  
During the asexual replication, the parasite refurbishes the host cell with exported proteins. In 
a large gene knock out screen, Maier and colleagues identified several proteins that are 
associated with the rigidification of the iRBCs (Maier et al., 2008): PF3D7_0730900 (PTP4), 
PF3D7_1002100 (PTP5), PF3D7_0102200 (RESA, Silva et al., 2005, Mills et al., 2007), 
PF3D7_0501300 (SBP1), PF3D7_0404600, PF3D7_0424400, PF3D7_0801900, and 
PF3D7_1401600. In other studies, PfEMP3 and STEVOR were shown to also contribute to 
increased iRBC membrane rigidity (Glenister et al., 2002, Sanyal et al., 2012). In this study 
we have assessed iRBC rigidity changes upon PF3D7_0702500 and MESA depletion and 
observed no effect. We expected MESA to have an influence on the deformability of iRBCs 
because of its position at the erythrocyte cytoskeleton (discussed in detail in chapter 4). For 
PF3D7_0702500 an indirect effect on iRBC deformability could be conceivable e.g. by 
interacting with or transporting of a protein directly involved in altering iRBC physical 
properties (PF3D7_1002100 (PTP5) and PF3D7_0501300 (SBP1) identified by Maier and 
colleagues (see above) are putative interaction partners of PF3D7_0702500 (chapter 2)).   
iRBC rigidification seems dependent on the combined action of a number of exported 
proteins. In support of this hypothesis is the observation that the various proteins involved in 
the process have different gene expression profiles not all matching the onset of iRBC rigidity 
increase. A further observation is that knob structures introduced on the iRBC surface have a 
limited impact on iRBC deformability.  KAHRP-deficient, knob-less iRBCs show only 
modest rigidity differences compared to wildtype iRBCs indicating a minor role of 
KAHRP/knobs in the rigidification of iRBCs (Sanyal et al., 2012).  
Interestingly, also some “softeners” were identified in Maier’s study on exported proteins 
required for rigidity: PF3D7_1478600 (PTP3), PF3D7_0220100, PF3D7_1016300 (GBP130), 
and PF3D7_1301400 (Maier et al., 2008). We found PFE1605w knock down iRBCs to have 
higher retention rates in microsphiltration, thus also putatively contributing to iRBC 
deformability. The first protein identified involved in decreasing membrane rigidity was 
Pf332 (Glenister et al., 2009). Waller and colleagues studied the interaction of Pf332 with the 
RBC cytoskeleton and found Pf332 to interact with actin (Waller et al., 2010). In summary, 
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the finding of proteins involved in iRBC deformability increase may be an indication of 
“active” rigidity modulation by the parasite. 
Direct and indirect interactions of parasite proteins with erythrocyte membrane cytoskeleton 
components lead to altered physical properties of the red blood cell. Further, iRBC 
deformability can be influenced by post-translational modifications of erythrocyte proteins. 
For instance, P. falciparum exported FIKK kinases were described to phosphorylate 
membrane skeleton proteins and thereby inducing alterations in biomechanical properties of 
the iRBCs (Nunes et al., 2010). In this project, post-translational modifications of the proteins 
of interest were not included in the characterization analysis. However, PF3D7_0702500, 
MESA and STARP have (predicted) phosphorylation sites (Treeck et al., 2011) and 
PF3D7_0702500 and MESA are putatively palmitoylated (Jones et al., 2012). A detailed 
study of the function of those post-translational modifications could give additional insights 
into the role and regulation of these proteins.  
iRBC deformability has become a malaria drug-development target. Drug-induced rigidity 
increase of circulating Plasmodium stages can enhance their removal by the spleen. In our 
study on the effect of the spiroindolone KAF246 on iRBC rigidity (chapter 6) we have 
observed reduced deformability upon drug treatment in both asexual and sexual stages. In the 
light of eliminating malaria, sexual stages have recently obtained more attention as they are 
relevant for parasite transmission. Immature gametocyte iRBCs (stage I-IV) show high 
retention rates in microsphiltration experiments as do asexual late stage iRBC. Interestingly, 
stage V gametocyte iRBC are highly deformable. The rigidity switch linked to gametocyte 
maturation may allow the transmissible stages to leave the bone marrow and enter the 
circulation, pass the spleen and be transmitted to mosquitoes (Tiburcio et al., 2012). The 
molecular mechanisms underlying this rigidity switch are starting to be understood. The 
interaction of the STEVOR cytoplasmic domain with the ankyrin complex of the iRBC was 
reported to be important for iRBC deformability. In more detail, the STEVOR cytoplasmic 
domain is phosphorylated by PKA. PKA activity is controlled by cAMP signaling. During 
immature gametocyte stages I-IV, low levels of the plasmodial phosphodiesterase PDEδ lead 
to high cAMP levels in the cell. Phosphorylation of STEVOR is activated. Upon gametocyte 
maturation (stage V) the phosphodiesterase PDEδ is highly expressed and cAMP levels 
decrease. PKA is thus inactive and the STEVOR phosphorylation level subsequently 
decreases which may weaken or abolish the interaction with the cytoskeleton and lead to 
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increased deformability of the cell (Ramdani et al., 2015, Naissant et al., 2016, Lavazec, 
2017).   
We tested whether KAF246 induced rigidification relies on the same STEVOR 
phosphorylation pathway described above.  This pathway is the only mechanism identified to 
date to be involved in the gametocyte rigidity switch. According to preliminary results, 
STEVOR doesn’t seem to be involved in the KAF246-induced rigidification of stage V 
gametocytes. Elucidating the KAF246 mode of action on gametocyte deformability will 
contribute to our understanding of the underlying molecular processes. 
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Conclusion and Outlook 
This thesis contributes to a better understanding of P. falciparum exported proteins during the 
intraerythrocytic life cycle. Three selected exported proteins expressed during the 
intraerythrocytic life cycle, namely PF3D7_0702500, MESA and STARP were characterized.  
Functional analysis suggested a role of PF3D7_0702500 in PfEMP1 transport efficiency 
between Maurer’s clefts and the erythrocyte membrane or the anchoring of PfEMP1 at the 
cytoskeleton. Future experiments should detail the nature of the electron-dense structures to 
which PF3D7_0702500 localizes to, and thereby give more insights into the underlying 
mechanism of the PF3D7_0702500 KO phenotype of reduced binding to CD36 endothelial 
receptors. The roles of MESA and STARP remain elusive. It is conceivable that they function 
in a different life cycle stage or in a different process than analyzed. The functional readouts 
used in this thesis focused on the surface presentation of PfEMP1 and biomechanical changes 
of the iRBC. Additional future experiments should include the analysis of an involvement of 
the proteins of interest in nutrient uptake or differentiation into other life stages (e.g. sexual 
commitment). The characterization of exported proteins and the understanding of their 
interplay will ultimately help to identify new intervention strategies against malaria and its 
transmission. 
During the work described in this thesis, I have established a useful tool for endogenous 
tagging of parasite genes by combining CRISPR/Cas9 and SLI genome editing technologies. 
A set of plasmids with different tags (3xHA, GFP, BirA*3xHA) and multiple cloning sites 
was generated and is available for sharing. This tagging-approach allows a reliable and time-
efficient generation of transgenic parasite cell lines.  Further, the microsphiltration method for 
assessing iRBC deformability was successfully established at the Swiss TPH and has proven 
to work reliably. This method is not only useful to assess asexual stage iRBC deformability 
but also gametocyte deformability and expands the toolbox of available assays at the institute.  
Finally, I have shown during this thesis that the increase of spiroindolone-induced rigidity of 
circulating Plasmodium stages can enhance their removal by the spleen. It will be interesting 
to look more into the mechanism of the induced rigidity changes, especially in gametocyte 
stages that are transmission-relevant.  
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Maurer’s clefts movement 
Introduction 
Maurer’s clefts are formed early in the intraerythrocytic lifecycle (approximately 2-6 hours 
post infection (hpi)) and are highly mobile in the first half of the lifecycle until they are 
immobilized around 22hpi (McMillan et al., 2013, Gruring et al., 2011).  
The mechanism and function of Maurer’s clefts immobilization is unclear. Interestingly, it 
coincides with surface presentation of PfEMP1 (Gruring et al., 2011). Thus it is conceivable 
that there is a functional relationship between Maurer’s clefts immobilization and PfEMP1 
surface presentation.  
Three main observations have been made that led to (different) hypothesis for the mechanism 
of Maurer’s clefts arrest. First, Maurer’s clefts change their morphology during the lifecycle 
from globular to disk-shaped. This may influence their motion properties (Kilian et al., 2013). 
Second, actin-like filaments have been observed that connect Maurer’s clefts with the 
erythrocyte membrane/knobs (Taraschi et al., 2003, Cyrklaff et al., 2011). They were not only 
suggested to be important for structural integrity of Maurer’s clefts (Cyrklaff et al., 2011) but 
also to be trafficking routes of vesicles (Taraschi et al., 2003). However, actin 
depolymerization by cytochalsin D did not abolish Maurer’s clefts arrest completely 
indicating that actin alone is not accountable for Maurer’s clefts immobilization (Kilian et al., 
2013). Third, tether-like structures associated with Maurer’s clefts were observed in electron 
microscopy (Hanssen et al., 2008, Hanssen et al., 2010, Pachlatko et al., 2010). To date, 
MAHRP2 is the only known resident tether protein (Pachlatko et al., 2010). Its location in 
very close proximity to Maurer’s clefts and that expression coincides with the arrest of 
Maurer’s clefts could indicate an involvement of MAHRP2 in the fixation of Maurer’s clefts. 
In a hypothesis-driven approach we set out to investigate the role of MAHRP2 in Maurer’s 
clefts movement arrest. To this end, MAHRP1 was endogenously GFP–tagged at the C-
terminus in 3D7 wildtype and MAHRP2 deficient cell lines. This allowed tracking of 
Maurer’s clefts movement and arrest in life cell imaging. 
 
Methods 
Cell culture and transfections 
P. falciparum 3D7 was cultured and transfected as described (Moll et al., 2013). Transfected 
parasites were positively selected with 10nM WR99210 (Jacobs Pharmaceuticals, Cologne, 
Germany), or 5mg ml−1 blasticidin (Sigma-Aldrich, Inc.)  
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Transfection constructs 
For endogenous tagging the plasmid pCRISPR_GFP2ABSD was used. 300-600bp long 
homology regions were designed and the gRNA was chosen with the CHOPCHOP software 
(Montague et al., 2014, Labun et al., 2016). gRNA recognition sequence mutations were 
introduced with the 5’homology region reverse primer to avoid re-cleavage of successfully 
tagged endogenous protein. The homology regions and gRNA were PCR amplified using 
primers listed in Supplementary Table 1 and cloned into pCRISPR_GFP2ABSD using the In-
Fusion® HD Cloning Kit (Clontech® Laboratories, Inc.).   
A MAHRP2 knock out cell line was obtained by double crossover homologous 
recombination. To increase homologous recombination efficiency, a longer DNA segment, 
namely the mahrp2 gene (PF3D7_1353200/PF13_0276) and its neighboring gene 
(PF3D7_1353100/PF13_0276) coding for an exported protein of unknown function, were 
replaced with a hDHFR resistance cassette. 275-276 KO was generated by cloning PCR 
amplified 5’UTR and 3’UTR (using primers listed in Supplementary Table 1) with AflII/SacII 
and NcoI/AvrII, respectively into the pCC1 plasmid (pCC1_PF13_0275-PF13_0276). After 
transfection, on/off drug selection cycling was performed to select for stably integrated 
constructs and remove residual episomal constructs. 
 
Western blot analysis 
Parasite saponin lysates were run on 4-12% Bis/Tris precast gels (NuPAGE®, Life 
Technologies) according to the manufacturer’s protocol. Protein transfer was performed with 
the iBlot 2.0 (Life Technologies). Subsequently, the membrane was blocked with 10% 
skimmed milk/TNT (100mM Tris, 150mM NaCl, 0.1% Tween) and probed with the first 
antibody in 3% skimmed milk/TNT at room temperature for 2h-O/N. After 6 washes for 5min 
with TNT the secondary antibody conjugated to HRP was incubated in the respective dilution 
in 3% skimmed milk/TNT for 2h at room temperature. After another 6 washes for 5min with 
TNT the signal was detected by Super Signal West Pico Chemiluminescent Substrate 
(Thermo Scientific) or LumiGlo Reserve Chemiluminescent Substrate (Seracare) according to 
the manufacturer’s protocol. The antibodies used were: mouse α-GFP (Roche, 1:250), mouse 
α-GAPDH (1:20’000), rabbit α-MAHRP1 (1:5000), rabbit α-MAHRP2 (1:1000), goat α-
mouse-HRP (Pierce, 1:5000), and goat α-rabbit-HRP (Pierce, 1:10’000). 
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Immunofluorescence Assay 
Thin blood smears of parasite cultures were fixed in ice-cold 60% methanol/40% acetone for 
2min. After air-drying of the smear, a small circle was drawn with a hydrophobic pen and the 
respective area was blocked with 3% BSA/PBS for 1h at room temperature in a humidified 
chamber. Then, the cells were incubated with mouse α-GFP (Roche, 1:100), rabbit α-SBP1 
(1:400) in 3% BSA/PBS for minimum 2h at room temperature in a humidified chamber. After 
3 washes with 3% BSA/PBS for 7min the secondary antibody (goat α-mouse Alexa488, goat 
α-rabbit Alexa568; all Invitrogen, 1:200) was applied in the appropriate dilution in 3% 
BSA/PBS for minimum 1h at room temperature in a humidified chamber. After another 3 
wash steps with 3% BSA/PBS for 7min each, a coverslip was mounted with 2µl 
VECTASHIELD® with DAPI (Vector Laboratories Inc.). For imaging a 63x oil-immersion 
lens (1.4 numerical aperture) on a Leica 5000 B microscope was used. The images were 
obtained by using the software Leica ApplicationSuite 4.4. and analyzed using Fiji 
(Schindelin et al., 2012). 
 
Life imaging 
For live imaging 1ml of a synchronously growing culture was pelleted and washed in 1ml 
PBS. Then, the pellet was resuspended in 100μl PBS and 2.5μl sample was mixed with 2.5μl 
VECTASHIELD® with DAPI (Vector Laboratories Inc.) on a glass slide and covered with a 
coverslip. The coverslip was sealed with nail polish and the sample was immediately imaged 
with a 63x oil-immersion lens on a Leica 5000 B microscope. The images were obtained and 
analyzed with Leica ApplicationSuite 4.4. and Fiji (Schindelin et al., 2012). 
For high content life imaging highly synchronous parasite cultures were stained with 
SiRHoechst (Spirochrome) for 20min in the dark at 37°C. After washing the cells in PBS, the 
hematocrit was adjusted to 0.05% in PBS and 200µl cell suspension was seeded in 96-well 
poly-D-lysine coated imaging plates (Greiner) and allowed to settle for 30min. Time series of 
40s with an image taken every 2s of one position/well of 12 wells/timepoint/cell line were 
taken at 14-18hpi/18-22hpi/22-26hpi/26-30hpi with the 60x Plan Apo objective. Images were 
acquired with the ImageXpress Micro XLS Widefield High-Content Imaging System 
(Molecular Devices) and the MetaXpress Analysis Software. 
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Results and Discussion 
Generation of endogenous MAHRP1-GFP expressing cell lines 
In order to follow Maurer’s clefts movement, MAHRP1, a resident Maurer’s cleft protein, 
was GFP-tagged at the C-terminus. We have introduced the tag in 3D7 parasites and 
MAHRP2 knock out parasites (275-276 KO) to investigate the function of MAHRP2 in 
Maurer’s clefts movement arrest (tethering). Successful integration of the tag in 2 
independent transfections (sp and dp) was confirmed by PCR (Figure 1A). Absence of 
MAHRP2 protein expression in the 275-276 KO/MAHRP1-GFP cell lines and MAHRP1-
GFP fusion protein expression was confirmed by Western blot (Figure 1B). Untagged 
MAHRP1 runs at around 30kDa whilst, MAHRP1-GFP runs at around 55kDa. We observed 
an additional band around 70kDa which could be the fused and uncleaved bsd cassette (bsd 
Western blot not shown). Immunofluorescent co-labeling of GFP and SBP1, a resident 
Maurer’s cleft protein, confirmed the correct localization of the MAHRP1-GFP fusion protein 
at Maurer’s clefts (Figure 1D). 
 
Life imaging of MAHRP1-GFP cell lines  
Life imaging of 3D7/MAHRP1-GFP and 275-276 KO/MAHRP1-GFP was performed in ring 
stages (14-18hpi) to verify that there is enough GFP fluorescence for time-lapse life imaging 
and that movement of Maurer’s clefts is visible. Figure 1E shows a time lapse over 20s with 
images taken every 5 seconds. The position of Maurer’s clefts is different between every 
picture reflecting the rapid movement of the organelles.  
In a next step we monitored Maurer’s clefts movement arrest by life imaging of tightly 
synchronized 3D7/MAHRP1-GFP and 275-276 KO/MAHRP1-GFP at 14-18hpi, 18-22hpi, 
22-26hpi, and 26-30hpi with a high content microscope. At the first time point (14-18hpi), all 
Maurer’s clefts were moving rapidly whereas at the last time point (26-30hpi) Maurer’s clefts 
movement stopped. We observed no significant difference in Maurer’s clefts motion behavior 
between the two cell lines.  
 
Conclusion 
In conclusion, we successfully generated the 3D7/MAHRP1-GFP and 275-276 
KO/MAHRP1-GFP cell lines which were suitable for life imaging of Maurer’s clefts 
movement. Unexpectedly, MAHRP2 does not seem sufficient to trigger Maurer’s clefts 
movement arrest although no tether-like structures could be retrieved in absence of MAHRP2 
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from ultracentrifugation experiments (Pachlatko et al., 2010). Therefore, the function of these 
structures and of MAHRP2, their only identified constituent, remains elusive. Repetition of 
the high content imaging experiment including more detailed analysis of Maurer’s clefts 
motion may give more insight in the contribution of MAHRP2 and tethers to Maurer’s clefts 
arrest. 
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Supplementary Table 1 
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Figure legends 
Figure 1: Generation of MAHRP1-GFP expressing cell lines. A: The GFP2ABSD cassette 
was successfully integrated into the genome of 3D7 and 275-276 KO as shown by PCR. 
Primers were chosen outside the homology regions. The expected band sizes are for 3D7 
1840bp and for MAHRP1-GFP 3558bp B: Western blot analysis with α-MAHRP2 antibody 
to confirm the absence of MAHRP2 in 275-276 KO cell lines. GAPDH was used as loading 
control. C: Western blot analysis with α-MAHRP1 and α-GFP antibodies shows expression of 
MAHRP1-GFP in the 3D7/MAHRP1-GFP and 275-276 KO/MAHRP1-GFP parasite lysates. 
α-GAPDH antibody was used as loading control. D: Immunofluorescence microscopy shows 
correct MAHRP1-GFP localization at Maurer’s clefts of 3D7/MAHRP1-GFP and 275-276 
KO/MAHRP1-GFP parasites probed with α-GFP and α-SBP1 antibodies. Scale bar 2µm. E: 
Life cell microscopy of 14-18hpi ring stage 3D7/MAHRP1-GFP and 275-276 KO/MAHRP1-
GFP parasites. Pictures are taken every 5s, scale bar 2µm. 
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Functional characterization of MAHRP1 domains 
The described study summarizes the findings of the Master students Eva Hitz, Stephan 
Wichers, and Eron Rushiti under the supervision of Beatrice Schibler and Sebastian Rusch. 
 
Introduction 
The membrane-associated histidine-rich protein 1 (MAHRP1) is a Maurer’s clefts resident 
protein. Its 249 amino acids (aa) code for a 29 kDa protein that is expressed in early ring 
stages and present throughout the intraerythrocytic life cycle. The protein contains a 
transmembrane domain and a histidine rich domain at the C-terminus (Figure 2A, Spycher et 
al., 2003).  
MAHRP1 has no specific export signal and thus belongs to the PNEPs. In order to identify 
MAHRP1 regions needed for export, Spycher and colleagues generated several cell lines 
episomally expressing MAHRP1 subdomain-GFP chimeras. The main findings of their study 
were: 1) the transmembrane domain is needed for MAHRP1 entry in to the ER, 2) aa 52-130 
are sufficient for correct MAHRP1 export to the Maurer’s clefts, 3) aa 131-169 may facilitate 
MAHRP1 delivery to Maurer’s clefts, and 4) the histidine repeats (aa 169-215) are not needed 
for correct MAHRP1 trafficking (Spycher et al., 2008). 
MAHRP1 is essential for PfEMP1 export to the erythrocyte surface. In MAHRP1 deficient 
cells, PfEMP1 remains inside the parasite and is not exported to the host cytosol (Spycher et 
al., 2006). We hypothesize that MAHRP1 interacts directly or indirectly with PfEMP1 in 
order to facilitate its export into the PV or through the PVM. 
The previously described MAHRP1 knock out (Spycher et al., 2008) was achieved by an 
unintended 5′ UTR single cross-over recombination that lead to the integration of the entire 
transfection plasmid into the parasite genome (instead of a double cross-over recombination 
event). This cell line was observed to revert to wildtype. Therefore, in this study we have 
generated a novel MAHRP1 knock out cell line by CRISPR/Cas9 genome editing that could 
be complemented episomally with different 5’-end GFP-tagged MAHRP1 fragments in order 
to identify MAHRP1 domains involved in PfEMP1 export. 
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Methods 
Cell culture and transfections 
P. falciparum 3D7 was cultured and transfected as described (Moll et al., 2013). Transfected 
parasites were positively selected with 10nM WR99210 (Jacobs Pharmaceuticals, Cologne, 
Germany), 5mg ml−1 blasticidin (Sigma-Aldrich, Inc.), negative selection was done with 1µM 
5-Fluorocytosine (Valeant Pharmaceuticals, Laval, CA).  
 
Transfection constructs 
To generate the MAHRP1 knock out cell line KOMIC #3, parasites were transfected with the 
pB-CC plasmid. The pB-CC plasmid contains the MAHRP1 specific gRNA under a U6 
promoter and sequence-specific 5’ and 3’ HRs flanking the positive selection cassette 
hDHFR. Further, the endonuclease Cas9 followed by a 2A skip peptide and the negative 
selection cassette yfcu followed by the 2A skip peptide and then by the positive selection 
cassette bsd are encoded on the plasmid. 300-700bp long homology regions flanking mahrp1 
were designed and a gRNA recognition site inside mahrp1 was chosen with the CHOPCHOP 
software (Montague et al., 2014, Labun et al., 2016). The homology regions were PCR 
amplified with primers M1_5HR fw 5’CATTATATAGAGATTATCCACAAATCCG, 
M1_5HR rv 5’CTCTATAATACAACAGAATAATGTTAC, M1_3HR fw 
5’ACCAGGAGAACC ATGTGATTGC, and M1_3HR rv 
5’GAAGTAACATTATTATGCGTG, and cloned into pB-CC by using the restriction sites 
SacII/AflII (5HR) and EcoRI/AvrII (3HR). The complementary gRNA oligos were annealed 
and cloned into pB-CC using the BtgZI restriction site (M1 KO gRNA fw 
5’GATCACGGACATGGACATGG and M1 KO gRNA rv 5’CCATGTCCA 
TGTCCGTGATC). 
To complement KOMIC#3 with different MAHRP1 domains, parasites were transfected with 
a pARL_GFP(bsd) plasmid. For this, mahrp1 fragments were PCR-amplified using primers 
M1_1-130 fw 5’ATGGCAGAGCAAGCAGCAGT, M1_1-130 rv 5’TGAGTGGTATA 
AGAAGGCGTG, M1_1-169 fw 5’ATGGCAGAGCAAGCAGCAGT, M1_1-169 rv 
5’CATATATTCTGG ATCAAA, M1_52-130 fw 5’ATGGATAACTATGCTAGGAA 
TTGG, M1_52-130 rv 5’TGAGTGGTATAAGAAGGCGTG, M1_52-249 fw 5’ATGGA 
TAACTATGCTAGGAATTGG, M1_52-249 rv 5’TTATCTTTTTTTTCTTGTTCTAATT 
TTGC, M1_1-169 fw 5’ATGGCAGAGCAAGCAGCAGT, M1_1-169 rv 5’CATATAT 
TCTGGATCAAAAAATGGGT, M1_1-215 fw 5’ATGGCAGAGCAAGCAGCAGT, M1_1-
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215 rv 5'TCCATGTCCGTGATCGTGTC, M1ΔTM fw 5'- ATGGCAGAGCAAGCAGTAC, 
M1ΔTM rv 5’ATTATCTTTTTTTTCTTGTTCTAAT and cloned upstream of the GFP-tag 
into pARL_GFP(bsd) using the restriction sites AflII and ClaI. 
 
Western blot analysis 
Parasite saponin lysates were run on 4-12% Bis/Tris precast gels (NuPAGE®, Life 
Technologies) according to the manufacturer’s protocol. Protein transfer was performed with 
the iBlot 2.0 (Life Technologies). Subsequently, the membrane was blocked with 10% 
skimmed milk/TNT (100mM Tris, 150mM NaCl, 0.1% Tween) and probed with the first 
antibody in 3% skimmed milk/TNT at room temperature for 2h-O/N. After 6 washes for 5min 
with TNT the secondary antibody conjugated to HRP was incubated in the respective dilution 
in 3% skimmed milk/TNT for 2h at room temperature. After another 6 washes for 5min with 
TNT the signal was detected by Super Signal West Pico Chemiluminescent Substrate 
(Thermo Scientific) or LumiGlo Reserve Chemiluminescent Substrate (Seracare) according to 
the manufacturer’s protocol. The antibodies used were: mouse α-GFP (Roche, 1:250), mouse 
α-ATS (1:100), rabbit α-MAHRP1 (1:5’000), mouse α-GAPDH (1:20’000), goat α-mouse-
HRP (Pierce, 1:5000), goat α-rabbit-HRP (Pierce, 1:10’000). 
 
Immunofluorescence microscopy 
Thin blood smears of parasite cultures were fixed in ice-cold 60% methanol/40% acetone for 
2min. After air-drying of the smear, a small circle was drawn with a hydrophobic pen and the 
respective area was blocked with 3% BSA/PBS for 1h at room temperature in a humidified 
chamber. Then, the cells were incubated with mouse α-GFP (Roche, 1:100), rabbit α-
MAHRP1 (1:500), mouse α-ATS (1:50) in 3% BSA/PBS for minimum 2h at room 
temperature in a humidified chamber. After 3 washes with 3% BSA/PBS for 7min the 
secondary antibody (goat α-mouse Alexa488, goat α-rabbit Alexa488; all Invitrogen, 1:200) 
was applied in the appropriate dilution in 3% BSA/PBS for minimum 1h at room temperature 
in a humidified chamber. After another 3 wash steps with 3% BSA/PBS for 7min each, a 
coverslip was mounted with 2µl VECTASHIELD® with DAPI (Vector Laboratories Inc.). 
For imaging a 63x oil-immersion lens (1.4 numerical aperture) on a Leica 5000 B microscope 
was used. The images were obtained by using the software Leica ApplicationSuite 4.4. and 
analyzed using Fiji (Schindelin et al., 2012). 
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Scanning electron microscopy 
For scanning electron microscopy mature parasites were knob-selected, purified by Percoll 
density gradient and fixed in 2.5% PBS for 1h at room temperature. After transfer to 
coverslips preliminary coated with Poly-L-lysine, the samples were dehydrated in increasing 
concentration of ethanol (10% v/v, 25% v/v, 50% v/v, 75% v/v, 90% v/v and 2 x 100% v/v, 
10min each), critical point dried and finally sputtered with 5nm Platinum (LEICA EM 
ACE600). The micrographs were taken with a SEM Versa 3D (FEI) at 5kV. 
 
Results and Discussion 
MAHRP1 knock out cell line generation, characterization and complementation with 
MAHRP1 fragments 
A MAHRP1 knock out cell line called knock out MAHRP1 complete #3 (KOMIC #3) was 
generated by CRISPR/Cas9-mediated double cross-over recombination. Based on the plasmid 
system from Ghorbal et al. (2014), we have designed a single plasmid approach, where Cas9, 
the gRNA and the repair template are provided on the same plasmid. Successful mahrp1 
disruption by replacement of the gene with a hDHFR resistance cassette was verified by 
Western blot (Figure 1A) and immunofluorescence assay (Figure 1B). In both assays a 
MAHRP1 signal was present in 3D7 control samples but absent in the KOMIC #3 samples 
indicating that MAHRP1 is not expressed in the KOMIC #3.  
We found chromosome 2 breaks occurring frequently in our lab culture strains and this 
chromosome break involves the loss of the kahrp gene resulting in knob deficient iRBCs 
(Lanzer et al., 1994). Since knobs are an important part of the P. falciparum virulence 
complex where the major virulence factor PfEMP1 is presented on the iRBC surface, we 
regularly selected our culture strains for presence of knobs by gelatin floatation (Malaria 
Methods and Protocols, Sixth Edition, 2013). Presence of knobs in the KOMIC #3 cell line 
was confirmed by scanning electron microscopy (Figure 1C).  
Maurer’s clefts morphology analyzed by immunoelectron microscopy seemed aberrant in 
KOMIC #3 compared to 3D7 wildtype infected red blood cells as previously described 
(Spycher et al., 2008). Further, we confirmed the finding that MAHRP1 deficient cells do not 
present PfEMP1 on the iRBC surface. In a trypsin cleavage assay KOMIC #3 samples 
contained only full-length, intracellular PfEMP1 as compared to 3D7 control where we 
detected the cleaved intracellular part of surface-exposed PfEMP1 (Figure 1D).  
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In order to get new insights into the function of the different MAHRP1 domains in MAHRP1 
trafficking and PfEMP1 export, the KOMIC #3 cell line was complemented with different 
MAHRP1 fragments (Figure 2A) fused to GFP. MAHRP1 full length (aa 1-249) was used as 
control. Previously, Spycher and colleagues concluded that the MAHRP1 aa 52-130 are 
sufficient to promote MAHRP1 export (Spycher et al., 2006) hence we wanted to confirm this 
by complementing KOMIC #3 with this fragment (MAHRP1 aa 52-130). We also wanted to 
confirm that the transmembrane domain is needed for MAHRP1 entry into the ER (Spycher et 
al., 2006) by transfecting a MAHRP1ΔTM construct into KOMIC #3. Further, we aimed to 
clarify the role of aa 130-169 in facilitating MAHRP1 export by analyzing KOMIC #3 
expressing a MAHRP1 aa 1-130 and a MAHRP1 aa 1-169 construct. The function of the C-
terminal histidine-rich domain of MAHRP1 had not been elucidated yet. Therefore, we 
compared the cell lines either expressing a MAHRP1 fragment truncated before the histidine-
rich domain (MAHRP1 aa 1-169) or expressing a fragment expressing MAHRP1 including 
the histidine repeats (MAHRP1 aa 1-215). Since MAHRP1 is a PNEP which needs an internal 
hydrophobic signal for efficient export (Spielmann and Gilberger, 2010) we wanted to test 
whether MAHRP1 aa 52-249 in the KOMIC #3 would be exported since Grüring et al. had 
shown that the first 20 aa of MAHRP1 mediated export of a reporter construct (Gruring et al., 
2012). 
Expression of all MAHRP1-GFP fragments was confirmed by Western blot (Figure 2B). The 
calculated molecular weight of the different MAHRP1-GFP fragments were 56 kDa, 37 kDa, 
51 kDa, 43 kDa, and 47 kDa for MAHRP1 full length, MAHRP1 aa 52-130, MAHRP1 aa 52-
249, MAHRP1 aa 1-130, and MAHRP1 aa 1-169, respectively. All fragments ran at the 
expected sizes.  
Transfections of KOMIC #3 with constructs MAHRP1 1-215, and MAHRP1ΔTM came up 
but expression of the GFP-fusion protein yet needs to be confirmed by Western blot. 
 
MAHRP1 export does not depend on its N-terminus (aa 1-52) 
Trafficking of all MAHRP1 fragments to Maurer’s clefts was monitored by 
immunofluorescence (Figure 3). KOMIC #3 as expected showed  no GFP signal (Figure 3, 
first panel) whilst MAHRP1 full length was observed at Maurer’s clefts (Figure 3, second 
panel). MAHRP1 aa 52-130 GFP signal was only detected inside the parasite, thus this 
fragment was not exported (Figure 3, third panel). This finding is in contrast to previously 
published data showing MAHRP1 aa 52-130 being the minimal construct needed for export 
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(Spycher et al. 2006). As previously observed MAHRP1 aa 1-130 was not found in all iRBC 
at Maurer’s clefts, in a proportion of cells it was not exported (Figure 3, fourth panel). This 
supports the hypothesis of Spycher and colleagues that aa 130-169 maybe required for export 
of MAHRP1 (Spycher et al., 2006). The construct MAHRP1 aa 1-169 has not yet been 
analyzed but may clarify the role of aa 130-169. MAHRP1 aa 52-249 (MAHRP1, fifth panel) 
was correctly transported to Maurer’s clefts indicating that the N-terminal region of MAHRP1 
is dispensable for export. The finding that aa 1-52 are dispensable for MAHRP1 export 
(shown with the construct MAHRP1 aa 52-249) indicates that MAHRP1 is an exception of 
the general PNEP export pathway requiring an N-terminal signal sequence (Heiber et al., 
2013). The finding also stands in contrast to the finding that MAHRP1 aa 1-20 are able to 
drive export of a reporter construct (Gruring et al., 2012). In summary, it seems that the 
MAHRP1 N-terminus is sufficient but not essential for protein export.  
Additionally, the export of the MAHRP1ΔTM and MAHRP aa 1-215 constructs in the 
respective cell lines will be analyzed which may allow to draw conclusions on the importance 
of the transmembrane domain and the histidine-rich domain in MAHRP1 trafficking to 
Maurer’s clefts. 
Contrasting results to the previous study of Spycher and colleagues (Spycher et al., 2006) may 
be explained by the fact that their assays were done in a 3D7 background with endogenous 
full length MAHRP1 still expressed whilst our assays were done in a complete MAHRP1 
knock out cell line. The presence of MAHRP1 may facilitate export of the truncated 
constructs (e.g. MAHRP1 aa 52-130) by an unknown co-transport mechanism.   
 
The MAHRP1 C-terminus (aa 130-249) is important for PfEMP1 export 
To identify MAHRP1 domains that enable PfEMP1 transport, immunofluorescence assays 
were performed with all complemented cell lines described above (Figure 2A). We used the 
α-ATS antibody to monitor PfEMP1 export to Maurer’s clefts but this antibody does not label 
PfEMP1 on the iRBC surface. We observed similar ATS signal at Maurer’s clefts in 3D7 and 
MAHRP1 full length complemented KOMIC #3 as expected (Figure 4, first and third panel). 
It was previously shown that MAHRP1 is needed for PfEMP1 export (Spycher et al., 2008) 
and we also confirmed the absence of surface exposed PfEMP1 in KOMIC #3 by trypsin 
cleavage assay (Figure 1D). Accordingly, we found no ATS signal at Maurer’s clefts in the 
KOMIC #3 cell line by immunofluorescence microscopy (Figure 4, second panel). The 
constructs MAHRP1 aa 52-130 (Figure 4, fourth panel) and MAHRP1 aa 1-130 (Figure 4, 
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fifth panel) were not able to restore PfEMP1 delivery to Maurer’s clefts, whereas MAHRP1 
aa 52-249 complemented KOMIC #3 showed PfEMP1 localization at Maurer’s clefts (Figure 
4, sixth panel). This suggests that the C-terminal part of MAHRP1 (aa 130-249) is important 
for the export of PfEMP1. Especially the analysis of the KOMIC #3 cell lines expressing 
MAHRP1 aa 1-169 and MAHRP1 aa 1-215 respectively will give insights whether the 
histidine-rich domain is important for direct or indirect interaction with PfEMP1.  
In a next step, cell lines expressing fragments that restore PfEMP1 transport to Maurer’s 
clefts should be analyzed on PfEMP1 presentation on the iRBC surface, either by trypsin 
cleavage or CD36 binding assays. 
Provided that a certain fragment/domain can be assigned to restore PfEMP1 export, additional 
experiments investigating the putative interaction between MAHRP1 and PfEMP1 should be 
performed. 
 
Summary and Outlook 
A new MAHRP1 knock out cell line called KOMIC #3 was generated and complemented 
with different GFP-tagged MAHRP1 fragments. Immunofluorescence assays were performed 
to investigate the role of different MAHRP1 domains in the export of MAHRP1 and PfEMP1. 
From the current results we conclude that 1) aa 130-169 seemed to be important for efficient 
MAHRP1 export and 2) the MAHRP1 C-terminus is important for PfEMP1 export. Analysis 
of the remaining cell lines will lead to more specific conclusions.  
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Figure legends 
Figure 1: Generation and characterization of MAHRP1 knock out cell line KOMIC #3. 
A: Western blot analysis of 3D7 and KOMIC #3 saponin lysates. The membrane was probed 
with α-MAHRP1 antibodies, GAPDH was used as loading control. B: Immunofluorescence 
analysis of thin smears of 3D7 and KOMIC #3 with α-MAHRP1 antibodies. C: Scanning 
electron microscopy of uninfected, 3D7 and KOMIC #3 infected red blood cells (iRBCs). 
Scale bar 1µm. D: Western blot analysis of trypsin cleavage assay with 3D7 and KOMIC #3 
samples. +T: trypsin treated, -T: control, not trypsin treated, RBC: red blood cells. The 
membrane was probed with the α-ATS antibody.  
 
Figure 2: Complementation of KOMIC #3. A: Schematic representation of MAHRP1 and 
the different complementation constructs. Indicated numbers are amino acid positions, TM: 
transmembrane domain, HHH: histidine-rich domain. B: Western blot analysis of 
complemented KOMIC #3 saponin lysates MAHRP1 full length (M1 FL), MAHRP1 aa 52-
130 (M1 52-130), MAHRP1 aa 52-249 (M1 52-249), MAHRP1 aa 1-130 (M1 1-130), and 
MAHRP1 aa 1-169 (M1 1-169). HP1-GFP was used as positive control. Membranes were 
probed with α-GFP antibody; GAPDH was used as loading control.  
 
Figure 3: Localization of MAHRP1 fragments in complemented KOMIC #3 cell lines. 
Immunofluorescence assay of thin smears of KOMIC #3, MAHRP1 full length (M1 FL), 
MAHRP1 aa 52-130 (M1 52-130), MAHRP1 aa 1-130 (M1 1-130), and MAHRP1 aa 52-249 
(M1 52-249) probed with α-MAHRP1 antibody.  
 
Figure 4: Localization of PfEMP1 in complemented KOMIC #3 cell lines. 
Immunofluorescence asssay of thin smears of 3D7, KOMIC #3, MAHRP1 full length (M1 
FL), MAHRP1 aa 52-130 (M1 52-130), MAHRP1 aa 1-130 (M1 1-130), and MAHRP1 aa 
52-249 (M1 52-249) probed with α-ATS antibody. 
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